<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T01:47:00Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:10629034" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:10629034</identifier>
        <datestamp>2023-11-08</datestamp>
        <setSpec>implemsci</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="research-article" dtd-version="1.3">
          <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
            <restricted-by>pmc</restricted-by>
          </processing-meta>
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">Implement Sci</journal-id>
              <journal-id journal-id-type="iso-abbrev">Implement Sci</journal-id>
              <journal-title-group>
                <journal-title>Implementation Science : IS</journal-title>
              </journal-title-group>
              <issn pub-type="epub">1748-5908</issn>
              <publisher>
                <publisher-name>BioMed Central</publisher-name>
                <publisher-loc>London</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC10629034</article-id>
              <article-id pub-id-type="pmcid">PMC10629034</article-id>
              <article-id pub-id-type="pmc-uid">10629034</article-id>
              <article-id pub-id-type="pmid">37932730</article-id>
              <article-id pub-id-type="pmid">37932730</article-id>
              <article-id pub-id-type="publisher-id">1308</article-id>
              <article-id pub-id-type="doi">10.1186/s13012-023-01308-w</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Study Protocol</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Protocol to evaluate sequential electronic health record-based strategies to increase genetic testing for breast and ovarian cancer risk across diverse patient populations in gynecology practices</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author" corresp="yes">
                  <name>
                    <surname>Symecko</surname>
                    <given-names>Heather</given-names>
                  </name>
                  <address>
                    <email>hsymecko@pennmedicine.upenn.edu</email>
                  </address>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                  <xref ref-type="aff" rid="Aff2">2</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Schnoll</surname>
                    <given-names>Robert</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                  <xref ref-type="aff" rid="Aff3">3</xref>
                  <xref ref-type="aff" rid="Aff4">4</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Beidas</surname>
                    <given-names>Rinad S.</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff5">5</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Bekelman</surname>
                    <given-names>Justin E.</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                  <xref ref-type="aff" rid="Aff3">3</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Blumenthal</surname>
                    <given-names>Daniel</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                  <xref ref-type="aff" rid="Aff4">4</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Bauer</surname>
                    <given-names>Anna-Marika</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                  <xref ref-type="aff" rid="Aff4">4</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Gabriel</surname>
                    <given-names>Peter</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                  <xref ref-type="aff" rid="Aff3">3</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Boisseau</surname>
                    <given-names>Leland</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Doucette</surname>
                    <given-names>Abigail</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                  <xref ref-type="aff" rid="Aff3">3</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Powers</surname>
                    <given-names>Jacquelyn</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                  <xref ref-type="aff" rid="Aff2">2</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Cappadocia</surname>
                    <given-names>Jacqueline</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                  <xref ref-type="aff" rid="Aff2">2</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>McKenna</surname>
                    <given-names>Danielle B.</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                  <xref ref-type="aff" rid="Aff2">2</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Richardville</surname>
                    <given-names>Robert</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                  <xref ref-type="aff" rid="Aff2">2</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Cuff</surname>
                    <given-names>Lauren</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                  <xref ref-type="aff" rid="Aff2">2</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Offer</surname>
                    <given-names>Ryan</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Clement</surname>
                    <given-names>Elizabeth G.</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Buttenheim</surname>
                    <given-names>Alison M.</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                  <xref ref-type="aff" rid="Aff3">3</xref>
                  <xref ref-type="aff" rid="Aff6">6</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Asch</surname>
                    <given-names>David A.</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                  <xref ref-type="aff" rid="Aff3">3</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Rendle</surname>
                    <given-names>Katharine A.</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                  <xref ref-type="aff" rid="Aff3">3</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Shelton</surname>
                    <given-names>Rachel C.</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff7">7</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Fayanju</surname>
                    <given-names>Oluwadamilola M.</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                  <xref ref-type="aff" rid="Aff3">3</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Wileyto</surname>
                    <given-names>E. Paul</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                  <xref ref-type="aff" rid="Aff4">4</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Plag</surname>
                    <given-names>Martina</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff8">8</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Ware</surname>
                    <given-names>Sue</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                  <xref ref-type="aff" rid="Aff4">4</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Shulman</surname>
                    <given-names>Lawrence N.</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                  <xref ref-type="aff" rid="Aff3">3</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Nathanson</surname>
                    <given-names>Katherine L.</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                  <xref ref-type="aff" rid="Aff2">2</xref>
                  <xref ref-type="aff" rid="Aff3">3</xref>
                </contrib>
                <contrib contrib-type="author" corresp="yes">
                  <name>
                    <surname>Domchek</surname>
                    <given-names>Susan M.</given-names>
                  </name>
                  <address>
                    <email>susan.domchek@pennmedicine.upenn.edu</email>
                  </address>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                  <xref ref-type="aff" rid="Aff2">2</xref>
                  <xref ref-type="aff" rid="Aff3">3</xref>
                </contrib>
                <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.25879.31</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 8972</institution-id><institution>Perelman School of Medicine, </institution><institution>University of Pennsylvania, </institution></institution-wrap>Philadelphia, PA USA </aff>
                <aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.25879.31</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 8972</institution-id><institution>Basser Center for BRCA, Perelman School of Medicine, </institution><institution>University of Pennsylvania, </institution></institution-wrap>Philadelphia, PA USA </aff>
                <aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/04h81rw26</institution-id><institution-id institution-id-type="GRID">grid.412701.1</institution-id><institution-id institution-id-type="ISNI">0000 0004 0454 0768</institution-id><institution>Penn Center for Cancer Care Innovation, </institution><institution>Abramson Cancer Center, Penn Medicine, </institution></institution-wrap>Philadelphia, PA USA </aff>
                <aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00b30xv10</institution-id><institution-id institution-id-type="GRID">grid.25879.31</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 8972</institution-id><institution>Center for Interdisciplinary Research On Nicotine Addiction, </institution><institution>University of Pennsylvania, </institution></institution-wrap>Philadelphia, PA USA </aff>
                <aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="GRID">grid.16753.36</institution-id><institution-id institution-id-type="ISNI">0000 0001 2299 3507</institution-id><institution>Feinberg School of Medicine, </institution><institution>Northwestern University, </institution></institution-wrap>Chicago, IL USA </aff>
                <aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00b30xv10</institution-id><institution-id institution-id-type="GRID">grid.25879.31</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 8972</institution-id><institution>School of Nursing, </institution><institution>University of Pennsylvania, </institution></institution-wrap>Philadelphia, PA USA </aff>
                <aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00hj8s172</institution-id><institution-id institution-id-type="GRID">grid.21729.3f</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 8729</institution-id><institution>Mailman School of Public Health, </institution><institution>Columbia University, </institution></institution-wrap>New York, NY USA </aff>
                <aff id="Aff8"><label>8</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/04h81rw26</institution-id><institution-id institution-id-type="GRID">grid.412701.1</institution-id><institution-id institution-id-type="ISNI">0000 0004 0454 0768</institution-id><institution>Center for Healthcare Transformation and Innovation, </institution><institution>Penn Medicine, </institution></institution-wrap>Philadelphia, PA USA </aff>
              </contrib-group>
              <pub-date pub-type="epub">
                <day>6</day>
                <month>11</month>
                <year>2023</year>
              </pub-date>
              <pub-date pub-type="pmc-release">
                <day>6</day>
                <month>11</month>
                <year>2023</year>
              </pub-date>
              <pub-date pub-type="collection">
                <year>2023</year>
              </pub-date>
              <volume>18</volume>
              <elocation-id>57</elocation-id>
              <history>
                <date date-type="received">
                  <day>29</day>
                  <month>8</month>
                  <year>2023</year>
                </date>
                <date date-type="accepted">
                  <day>29</day>
                  <month>9</month>
                  <year>2023</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>© The Author(s) 2023</copyright-statement>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
                  <license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated in a credit line to the data.</license-p>
                </license>
              </permissions>
              <abstract id="Abs1">
                <sec>
                  <title>Background</title>
                  <p id="Par1">Germline genetic testing is recommended by the National Comprehensive Cancer Network (NCCN) for individuals including, but not limited to, those with a personal history of ovarian cancer, young-onset (&lt; 50 years) breast cancer, and a family history of ovarian cancer or male breast cancer. Genetic testing is underused overall, and rates are consistently lower among Black and Hispanic populations. Behavioral economics-informed implementation strategies, or nudges, directed towards patients and clinicians may increase the use of this evidence-based clinical practice.</p>
                </sec>
                <sec>
                  <title>Methods</title>
                  <p id="Par2">Patients meeting eligibility for germline genetic testing for breast and ovarian cancer will be identified using electronic phenotyping algorithms. A pragmatic cohort study will test three sequential strategies to promote genetic testing, two directed at patients and one directed at clinicians, deployed in the electronic health record (EHR) for patients in OB-GYN clinics across a diverse academic medical center. We will use rapid cycle approaches informed by relevant clinician and patient experiences, health equity, and behavioral economics to optimize and de-risk our strategies and methods before trial initiation. Step 1 will send patients messages through the health system patient portal. For non-responders, step 2 will reach out to patients via text message. For non-responders, Step 3 will contact patients’ clinicians using a novel “pend and send” tool in the EHR. The primary implementation outcome is engagement with germline genetic testing for breast and ovarian cancer predisposition, defined as a scheduled genetic counseling appointment. Patient data collected through the EHR (e.g., race/ethnicity, geocoded address) will be examined as moderators of the impact of the strategies.</p>
                </sec>
                <sec>
                  <title>Discussion</title>
                  <p id="Par3">This study will be one of the first to sequentially examine the effects of patient- and clinician-directed strategies informed by behavioral economics on engagement with breast and ovarian cancer genetic testing. The pragmatic and sequential design will facilitate a large and diverse patient sample, allow for the assessment of incremental gains from different implementation strategies, and permit the assessment of moderators of strategy effectiveness. The findings may help determine the impact of low-cost, highly transportable implementation strategies that can be integrated into healthcare systems to improve the use of genomic medicine.</p>
                </sec>
                <sec>
                  <title>Trial registration</title>
                  <p id="Par4">ClinicalTrials.gov. NCT05721326. Registered February 10, 2023. <ext-link ext-link-type="uri" xlink:href="https://www.clinicaltrials.gov/study/NCT05721326">https://www.clinicaltrials.gov/study/NCT05721326</ext-link></p>
                </sec>
                <sec>
                  <title>Supplementary Information</title>
                  <p>The online version contains supplementary material available at 10.1186/s13012-023-01308-w.</p>
                </sec>
              </abstract>
              <kwd-group xml:lang="en">
                <title>Keywords</title>
                <kwd>Genetic testing</kwd>
                <kwd>Behavioral economics</kwd>
                <kwd>Nudges</kwd>
                <kwd>Implementation science</kwd>
                <kwd>Electronic health record</kwd>
                <kwd>Sequential</kwd>
                <kwd>Pragmatic</kwd>
                <kwd>Rapid cycle approaches</kwd>
              </kwd-group>
              <funding-group>
                <award-group>
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000054</institution-id>
                      <institution>National Cancer Institute</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>P50CA244690</award-id>
                  <principal-award-recipient>
                    <name>
                      <surname>Schnoll</surname>
                      <given-names>Robert</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
              </funding-group>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>issue-copyright-statement</meta-name>
                  <meta-value>© BioMed Central Ltd., part of Springer Nature 2023</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
          </front>
          <body>
            <sec id="Sec1">
              <boxed-text>
                <label>Contributions to the literature</label>
                <p id="Par20">
                  <list list-type="bullet">
                    <list-item>
                      <p id="Par21">•This study will evaluate novel sequential steps to promote the use of genetic testing to determine breast and ovarian cancer predisposition.</p>
                    </list-item>
                    <list-item>
                      <p id="Par22">•This study will be one of the first to use implementation strategies informed by behavioral economics directed to both patients and clinicians to increase the use of genetic testing for breast and ovarian cancer predisposition across a large health system.</p>
                    </list-item>
                    <list-item>
                      <p id="Par23">•This study may provide support for low-cost, simple, and scalable approaches to increasing the engagement of at-risk patients with breast and ovarian cancer genetic testing.</p>
                    </list-item>
                  </list>
                </p>
              </boxed-text>
            </sec>
            <sec id="Sec2">
              <title>Background</title>
              <p id="Par24">Breast cancer is the most common cancer for women across the world [<xref ref-type="bibr" rid="CR1">1</xref>–<xref ref-type="bibr" rid="CR3">3</xref>]. Approximately 300,000 new breast cancer cases were estimated in the USA for 2022, accounting for roughly one-third of new cancer diagnoses among U.S. women [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>]. Although less common, ovarian cancer ranks as the deadliest gynecologic cancer, accounting for about 20,000 cases and 13,000 deaths per year [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR7">7</xref>]. Moreover, substantial health inequities exist for both cancers. Early-stage diagnosis is critical for increasing survival rates [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR9">9</xref>], but Black women tend to be diagnosed at later stages than white women [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR10">10</xref>], and mortality rates for both diseases are &gt; 30% higher for Black women as compared to white women [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR12">12</xref>].</p>
              <p id="Par25">In the past decade, multigene panel tests have been increasingly used to analyze several genes associated with breast and ovarian cancer [<xref ref-type="bibr" rid="CR13">13</xref>–<xref ref-type="bibr" rid="CR15">15</xref>]. Genetic testing can inform risk assessment, suggest interventions for risk reduction, and change options for therapy [<xref ref-type="bibr" rid="CR16">16</xref>]. Multiple FDA approvals for PARP inhibitors for the treatment for BRCA-associated cancer, including early-stage, high-risk breast cancer [<xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR18">18</xref>], have changed the landscape with regard to medical intervention [<xref ref-type="bibr" rid="CR19">19</xref>]. As such, patients [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR21">21</xref>] and clinicians [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR23">23</xref>] are generally interested in genetic testing and the National Comprehensive Cancer Network (NCCN) recommends testing for specific groups (e.g., people with personal histories of ovarian cancer) [<xref ref-type="bibr" rid="CR14">14</xref>]. Unfortunately, there is a clear practice gap in genetic testing uptake, with only about 35% of ovarian cancer patients undergoing testing [<xref ref-type="bibr" rid="CR24">24</xref>–<xref ref-type="bibr" rid="CR27">27</xref>]. In assessing two large gynecology practices in our health system, we found higher rates than average of genetic testing among patients diagnosed within the last two years with early-onset breast cancer or triple-negative breast cancer. However, we found very low rates of genetic testing in individuals who were (1) diagnosed with ovarian cancer previously, or (2) had a family history of ovarian cancer or male breast cancer. Testing rates of those with a family history (rather than a personal history) of cancer were less than 15%. Moreover, substantial health inequities exist in testing rates. Eligible Black women are much less likely to be tested than their non-Hispanic white counterparts [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR25">25</xref>–<xref ref-type="bibr" rid="CR28">28</xref>], a finding replicated in the analysis of our own data, even with similar referral rates for all patients meeting our eligibility criteria.</p>
              <p id="Par26">Barriers to genomic medicine uptake exist at the system, clinician, and patient levels. The number of available genetic tests is growing exponentially [<xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR30">30</xref>], so it can be challenging to integrate genomic data into the electronic health record (EHR) to track genetic test results and facilitate clinical workflows [<xref ref-type="bibr" rid="CR31">31</xref>–<xref ref-type="bibr" rid="CR33">33</xref>]. Our health system has tackled this issue by using Health Level 7 (HL7) standardization with labs, genomic indicators, and a precision medicine tab within the EHR [<xref ref-type="bibr" rid="CR34">34</xref>]. However, due to expanding and changing indications and unclear eligibility criteria [<xref ref-type="bibr" rid="CR35">35</xref>], clinicians may face challenges in identifying those eligible for genetic testing. Also, they report barriers related to a lack of awareness or training, cost concerns, and busy schedules [<xref ref-type="bibr" rid="CR33">33</xref>, <xref ref-type="bibr" rid="CR35">35</xref>–<xref ref-type="bibr" rid="CR39">39</xref>], resulting in uncertainty and lower priority for referring patients to genetic counseling. Integrating genomic medicine into the EHR can mitigate some concerns by identifying appropriate patients and guiding clinicians via streamlined workflows [<xref ref-type="bibr" rid="CR34">34</xref>, <xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR40">40</xref>, <xref ref-type="bibr" rid="CR41">41</xref>]. Still, when faced with uncertainty, people often rely on cognitive heuristics to make decisions [<xref ref-type="bibr" rid="CR42">42</xref>], such as status quo bias, or preferring to maintain the current state over taking action to change [<xref ref-type="bibr" rid="CR40">40</xref>]. When perceiving unclear eligibility criteria or facing a busy schedule, clinicians may opt to keep things the same to maintain simplicity. The status quo bias can be leveraged by shifting the status quo to default genetics consult orders and emphasizing the availability of EHR-based support systems and clear recommendations for genetic testing. Similarly, default orders can make the referral process easier.</p>
              <p id="Par27">Given the shared decision-making dynamics underlying the choice to pursue genetic testing, patient barriers also must be addressed, including awareness [<xref ref-type="bibr" rid="CR43">43</xref>–<xref ref-type="bibr" rid="CR45">45</xref>], access [<xref ref-type="bibr" rid="CR46">46</xref>], cost concerns [<xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR43">43</xref>–<xref ref-type="bibr" rid="CR47">47</xref>], anxiety about the potential misuse of test results [<xref ref-type="bibr" rid="CR45">45</xref>, <xref ref-type="bibr" rid="CR48">48</xref>, <xref ref-type="bibr" rid="CR49">49</xref>], and insurance discrimination [<xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR50">50</xref>]. Patients’ decisions are also affected by cognitive heuristics. Omission bias, or focusing on the potential harm of action more than that of inaction [<xref ref-type="bibr" rid="CR51">51</xref>], plays a key role. Concerns about the implications of test results for patients and their families (such as the need for family members to be tested or fear about how medical professionals or insurance companies may use test results) can trigger omission bias and lead patients to think that getting genetic testing is worse than not pursuing it [<xref ref-type="bibr" rid="CR52">52</xref>, <xref ref-type="bibr" rid="CR53">53</xref>]. These concerns tend to be heightened among members of racial or ethnic minority groups who have been mistreated by the medical system [<xref ref-type="bibr" rid="CR45">45</xref>, <xref ref-type="bibr" rid="CR48">48</xref>, <xref ref-type="bibr" rid="CR49">49</xref>]. Although clinician recommendations to pursue genetic testing are one of the strongest predictors of patient willingness to undergo testing [<xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR54">54</xref>, <xref ref-type="bibr" rid="CR55">55</xref>], clinicians are significantly less likely to recommend it to Black and Hispanic women [<xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR54">54</xref>, <xref ref-type="bibr" rid="CR56">56</xref>]. Increasing the use of genetic testing requires addressing barriers at multiple levels [<xref ref-type="bibr" rid="CR57">57</xref>], many of which are salient for patients from minoritized groups. Thus, offering patients the opportunity to be involved in decision-making about genetic testing is crucial for facilitating sustainable and equitable uptake [<xref ref-type="bibr" rid="CR43">43</xref>].</p>
              <p id="Par28">Leveraging behavioral economic theory to mitigate cognitive heuristics has been effective in promoting evidence-based care and improving patient outcomes [<xref ref-type="bibr" rid="CR58">58</xref>–<xref ref-type="bibr" rid="CR62">62</xref>]. Nudges are strategies that make it easier for clinicians and patients to make evidence-based decisions. These can include framing language and/or default options, which subtly change the environment to facilitate evidence-based decisions while still preserving people’s freedom of choice [<xref ref-type="bibr" rid="CR60">60</xref>, <xref ref-type="bibr" rid="CR63">63</xref>]. For instance, emphasizing the ease of genetic testing and the harms of not taking the first steps toward an appointment could mitigate omission bias. For clinicians, nudges can incorporate accountable justification, which requires clinicians to substantiate their decisions when declining a new status quo (in the form of a default order) and can promote self-reflection and higher-value care [<xref ref-type="bibr" rid="CR64">64</xref>, <xref ref-type="bibr" rid="CR65">65</xref>].</p>
              <p id="Par29">Health system nudges have the potential to encourage uptake of genetic testing. These strategies can be automated, are scalable, and could mitigate health inequities [<xref ref-type="bibr" rid="CR40">40</xref>, <xref ref-type="bibr" rid="CR62">62</xref>, <xref ref-type="bibr" rid="CR66">66</xref>, <xref ref-type="bibr" rid="CR67">67</xref>]. Prior research suggests that clinicians recommend genetic testing less often for non-white patients [<xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR54">54</xref>, <xref ref-type="bibr" rid="CR56">56</xref>], but sequential dissemination of strategies could expand reach. Initial messages sent via the health system patient portal (MyPennMedicine; MPM) could generate initial interest via a “low-touch” message with minimal costs. Outreach via text messaging, which is more widespread [<xref ref-type="bibr" rid="CR68">68</xref>], will be able to mitigate inequities resulting from differential patient portal access [<xref ref-type="bibr" rid="CR69">69</xref>] and facilitate comparisons of outreach strategies. To reduce clinician burden, clinicians will only be contacted in the final phase. Literature suggests that clinician-directed default nudges, which sit atop the nudge intervention ladder, may be the most influential in changing behavior [<xref ref-type="bibr" rid="CR62">62</xref>, <xref ref-type="bibr" rid="CR66">66</xref>].</p>
              <p id="Par30">This study was designed to evaluate the effects of three sequentially delivered patient- and clinician-directed implementation strategies informed by behavioral economics on the scheduling of genetic counseling appointments for patients with breast and ovarian cancer risk. We chose a sequential study design to determine the relative effects of the three strategies. Adaptive designs are gaining in use, including in oncology [<xref ref-type="bibr" rid="CR70">70</xref>], since they can efficiently help identify the relative benefits of adding components of an intervention in relationship to the overall resources needed to sustain them. Behavioral economics and implementation science can be integrated to maximize the impact and equity of strategies seeking to encourage patients to pursue genetic testing [<xref ref-type="bibr" rid="CR63">63</xref>].</p>
            </sec>
            <sec id="Sec3">
              <title>Methods</title>
              <sec id="Sec4">
                <title>Study design</title>
                <p id="Par31">This pragmatic study will use a non-randomized, sequential adaptive design to examine the effect of patient- and clinician-directed nudges informed by behavioral economics and delivered via the EHR for promoting the use of genetic testing for the identification of breast and ovarian cancer predisposition. Sequences are detailed in Fig. <xref rid="Fig1" ref-type="fig">1</xref>. Before the sequences begin, we will use electronic phenotyping procedures to identify a cohort of patients receiving care through two large OB-GYN clinics who are eligible for genetic testing for breast and ovarian cancer predisposition (based on information in the EHR), but who have no documentation of testing in the EHR [<xref ref-type="bibr" rid="CR71">71</xref>]. Next, in the first sequence, all patients will be contacted via the MyPennMedicine (MPM) patient portal. Messages will be delivered twice, one week apart. The message will include direct information on patients’ cancer risk based on their genetic history, their ability to take action to address their risk, and how to contact the study team to schedule an appointment. Patients can reply directly to the MPM message, call the Cancer Risk Evaluation Program (CREP), or use an outreach-specific email address. Patients who do not engage with the CREP within three weeks will receive the next adaptive sequence, a direct text message targeting omission bias to promote breast and ovarian cancer genetic testing. Again, patients will receive two text messages, a week apart, and will be given three weeks to schedule an appointment. The text message program will be conducted through Penn Way to Health, an evidence-based patient engagement platform [<xref ref-type="bibr" rid="CR72">72</xref>, <xref ref-type="bibr" rid="CR73">73</xref>]. Finally, if patients do not engage with the genetics team, their clinicians will receive an EHR-based nudge targeting status quo bias using the “pend and send” functionality with a pended genetics consult order as a default. A final 6-month observation period will track the scheduling of genetic counseling and genetic testing results for breast and ovarian cancer predisposition following clinician strategy delivery. Patient characteristics (e.g., age, race/ethnicity, nature of genetic risk) will be ascertained from the EHR and explored as moderators of the effectiveness of each sequence to promote genetic testing. This sequential adaptive design will allow for comparisons of which strategies work best across clinics and subgroups of patients.<fig id="Fig1"><label>Fig. 1</label><caption><p>Study design</p></caption><graphic xlink:href="13012_2023_1308_Fig1_HTML" id="MO1"/></fig></p>
                <p id="Par32">The primary implementation outcomes will be rates of scheduling and completion of genetic counseling appointments, stratified by factors such as referral clinic and diagnosis, with cumulative nudges representing a time-varying covariate. Decisions to undergo genetic testing in a timely manner are dependent on several factors, including patient preference. Additionally, a counseling discussion can alleviate some patient concerns about testing and may be more acceptable to patients. As such, scheduling the initial genetic counseling appointment was chosen as a primary outcome in addition to appointment completion. Process outcomes will include open rates for the two patient-directed strategies and the proportion of pended orders signed by referring clinicians. We will compare the number of appointments scheduled after each sequence and across patient-level characteristics (e.g., race and ethnicity) and site.</p>
              </sec>
              <sec id="Sec5">
                <title>Study setting, population, and duration</title>
                <p id="Par33">This study will be conducted at gynecologic practices within two Penn Medicine centers: Penn Health for Women Radnor and the Helen O. Dickens Center for Women. These sites serve substantially different patient populations in terms of racial identity and insurance coverage, which may affect testing uptake. Most patients at Radnor are white (83.7% white, 6.5% Black, 3.0% Asian, 6.8% other/unknown), while the Dickens Center predominantly serves Black patients (73.7% Black, 18.9% white, 2.1% Asian, 5.3% other/unknown). Patients seen at these two sites since January 1, 2009 will be selected by an EHR-based algorithm established previously [<xref ref-type="bibr" rid="CR71">71</xref>] using the following eligibility criteria: (1) serous ovarian cancer diagnosed more than two years prior to study contact; (2) breast cancer diagnosed at under 50 years of age more than two years prior to study contact; (3) triple-negative breast cancer diagnosed at any age more than two years prior to study contact; (4) unaffected individuals reporting a family history of ovarian cancer; (5) unaffected individuals reporting a family history of male breast cancer; and (6) at least two Penn Medicine appointments within the last three years. Utilizing electronic phenotyping in the EHR, participants who have previously received genetic counseling and testing will be excluded. Approximately, 3000 patients at these sites have been identified as eligible for genetic testing for familial high-risk breast and ovarian cancer based on these criteria, and these patients make up the target sample. The clinician sample (<italic>N</italic> = 30) will consist of gynecologists at participating practice sites associated with these patients. It is anticipated that the study will take approximately 18 months to complete. The study was approved by the University of Pennsylvania Institutional Review Board. The trial presents minimal risks to participants, and a waiver of informed consent was approved for all study aims.</p>
              </sec>
              <sec id="Sec6">
                <title>Overview of rapid-cycle approaches and study procedures</title>
                <p id="Par34">The first step to increasing genetic testing is to identify patients who might benefit from it by utilizing updated tools in the EHR. Penn Medicine’s Abramson Cancer Center Electronic Phenotyping Core developed algorithms for identifying patients based on cancer registry data and family history fields in the EHR. These electronic phenotyping procedures were used to identify randomly selected patients to include in pilot testing during the rapid cycle approaches (RCAs).</p>
                <p id="Par35">As a project led by the National Cancer Institute-funded Penn Implementation Science Center in Cancer Control (Penn ISC3; P50CA244690), this study builds on strategies from the center’s prior research [<xref ref-type="bibr" rid="CR74">74</xref>, <xref ref-type="bibr" rid="CR75">75</xref>]. As in prior studies, RCAs to quickly learn and innovate from pilot tests [<xref ref-type="bibr" rid="CR41">41</xref>, <xref ref-type="bibr" rid="CR76">76</xref>–<xref ref-type="bibr" rid="CR78">78</xref>] were used to de-risk and optimize our nudges as implementation strategies. They also helped us refine our methods based on relevant experiences from clinicians and patient partners to maximize their effect and study efficiency. This work is summarized in Table <xref rid="Tab1" ref-type="table">1</xref>. RCAs involved advisory meetings with experts in behavioral economics, discussions with patient and family partners on the Basser Young Leadership Council, and meetings with clinicians with expertise in breast and ovarian cancer genetic testing. In addition, given the calls to incorporate implementation science and health equity together in genomic medicine [<xref ref-type="bibr" rid="CR43">43</xref>, <xref ref-type="bibr" rid="CR79">79</xref>], experts at integrating these fields provided guidance on study design and message content. We then designed prototype messages and received feedback about content and delivery mechanisms. Finally, two template patient nudges were pilot-tested by randomizing 200 patients to one of two messages that were based on different heuristics. After patients were sent their arm’s respective pilot message via the patient portal and text message, the proportions of patients who engaged with messages, contacted the CREP scheduling staff and scheduled a genetic counseling appointment were assessed. Based on extensive review from partners and pilot test results, the nudges to be implemented in the overall study were designed as follows.
<table-wrap id="Tab1"><label>Table 1</label><caption><p>Rapid cycle approaches to develop, de-risk, and optimize implementation strategies</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Domain</th><th align="left">Initial approach</th><th align="left">Iterative work</th><th align="left">Output</th></tr></thead><tbody><tr><td align="left">Clinician nudge</td><td align="left"><p>Best practice alert (BPA) with pended order for genetics counseling</p><p>Key questions:</p><p>• What is the best timing and mechanism for sending clinician nudges, since eligible patients won’t be in the clinic very often?</p><p>• What are the key cognitive heuristics affecting genetic testing ordering? </p></td><td align="left"><p>Method: Meetings with experts in behavioral science, implementation science, health equity, and informatics; discussions with clinicians</p><p>Key feedback:</p><p>• Alert fatigue can cause annoyance for care team members</p><p>• Clinicians preferred a pre-selected recommendation which can be signed efficiently</p><p>• Status quo bias was a key barrier</p></td><td align="left">“Pend and send” default order for genetic testing with accountable justification for clinicians who decline the order</td></tr><tr><td align="left">Patient nudge</td><td align="left"><p>Sequential nudges delivered via the patient portal and text message</p><p>Key questions:</p><p>• What strategies can be used to overcome inequities in patient portal access?</p><p>• What are the key cognitive heuristics affecting genetic testing uptake? </p></td><td align="left"><p>Method: Meetings with experts in behavioral science, implementation science and health equity; patient review; pilot tests which contacted 200 patients via the patient portal and text message with two potential nudges</p><p>Key feedback:</p><p>• Messages with a clear call to action up front can spur behavior change</p><p>• Wording changes to increase readability would be valuable</p><p>• Pilot tests revealed that the message emphasizing ease led to high engagement</p></td><td align="left">Patient portal messages emphasizing ease and text messages emphasizing the importance of taking action to prevent cancer</td></tr></tbody></table></table-wrap></p>
              </sec>
              <sec id="Sec7">
                <title>Patient nudges (patient portal and text message)</title>
                <p id="Par36">The patient-directed strategies will be delivered via two mechanisms: the patient portal and text message. Figure <xref rid="Fig2" ref-type="fig">2</xref> shows both patient-directed nudges. The content of the nudges was influenced by past research documenting that patients tend to focus on the potential adverse effects of action vs. inaction [<xref ref-type="bibr" rid="CR52">52</xref>, <xref ref-type="bibr" rid="CR53">53</xref>, <xref ref-type="bibr" rid="CR80">80</xref>] and was reviewed and modified by a group of clinicians and patient partners. Eligible patients will initially be contacted via the patient portal. This “low-touch” implementation strategy can provide information about the impact of using patient health system portals to encourage the uptake of genetic testing. If patients do not respond, or if they are identified as not having a patient portal account, they will be moved to the second implementation sequence. In this sequence, patients will be sent text messages using similar content from the first sequence, encouraging them to sign up for genetic counseling appointments. Patients who do not respond to the first two nudges will be identified for the clinician's nudge.<fig id="Fig2"><label>Fig. 2</label><caption><p>Patient nudges</p></caption><graphic xlink:href="13012_2023_1308_Fig2_HTML" id="MO2"/></fig></p>
              </sec>
              <sec id="Sec8">
                <title>Clinician nudge</title>
                <p id="Par37">Our preliminary formative work involved the development of prototype messages to integrate as nudges delivered to clinicians through the EHR. As with the patient nudge, we created multiple versions of the nudges and ascertained feedback from partners about the message content and design, as well as the method and timing of delivery. Also, the study team engaged with research from another study promoting genetic testing and adapted the wording and format of a clinician nudge to design a message considered most likely to receive clinician support.</p>
                <p id="Par38">Both study sites use Epic (Epic Systems Corporation, Verona, WI) to deliver care. Recent upgrades to Penn’s Epic instance introduced the “pend and send” capability. Using this process, the research team will create a pended order for a genetics consult for eligible patients who did not respond to prior patient-directed strategies. As detailed in Fig. <xref rid="Fig3" ref-type="fig">3</xref>, the clinician nudge will include text leveraging status quo bias, a default order for a genetics consult, and a requirement for clinicians to provide accountable justification if they decline the order. Clinicians can efficiently sign orders in the InBasket without needing to open each encounter separately. The consults are then routed directly to the CREP scheduling team, who will contact the patient to schedule an appointment with a genetic counselor. We pilot-tested the “pend and send” mechanism in the RCAs. Clinicians have been engaged at both clinics so that they are aware of this initiative and clinician education has been provided.<fig id="Fig3"><label>Fig. 3</label><caption><p>Clinician nudge</p></caption><graphic xlink:href="13012_2023_1308_Fig3_HTML" id="MO3"/></fig></p>
              </sec>
              <sec id="Sec9">
                <title>Measures</title>
                <p id="Par39">The primary outcomes are the rates of contacted patients who schedule and complete a genetic counseling appointment within six months after each sequential step, collected via the EHR. As process measures, we will evaluate the proportion of patients who open MPM messages or respond to text messages within one month of receiving them, as well as the proportion of pended orders that clinicians sign within one month to refer patients for a genetics consult. Potential moderating variables will also be collected, including patient demographics (age, race, ethnicity, diagnosis, health insurance, address, and geocoded area as a proxy for neighborhood-level socioeconomic status), clinician data (practice site, years in practice), and practice-level information (community vs. hospital-based setting, urban vs. non-urban location, health insurance mix). These data will be used to describe the sample of participating patients and clinicians and to identify factors that may influence strategy effectiveness. Genetic counseling and testing rates will be evaluated after being stratified by these factors.</p>
              </sec>
              <sec id="Sec10">
                <title>Sample size, power, and statistical analysis</title>
                <p id="Par40">Based on preliminary assessments via electronic phenotyping in the EHR, we have identified a target sample of around 3000 patients (clustered within approximately 30 physicians at the two Penn Medicine sites) who may benefit from genetic testing for familial high-risk breast and ovarian cancer predisposition but have not done so. We calculated power conservatively by assuming correlations of 0 to 0.2, using PASS (Power and Sample Size, NCSS Software, Kaysville, UT). We found our sample gives us 80% power to detect at least a 5% improvement in our cumulative incidence of testing using a two-sided type 1 error rate of 5%, for planned comparisons between each stage in the sequence.</p>
                <p id="Par41">We will analyze the change in the incidence of scheduling counseling appointments across the three sequences (all time to event outcomes) using Cox regression, with variances adjusted for physician clustering. The models will contain time-varying binary predictor terms for each nudge, making adjustments for time in months, and fixed effects for site. We will control for type 1 error inflation by hierarchical testing, starting with the overall model significance, followed by the effect of each strategy. Once we have fitted the main effects model, we will test for each sequence and retain terms if significant (alpha = 5%). Variability in outcomes by sequence and moderators (particularly health equity variables) will be assessed using interaction terms within Cox regression models. We will fit an adjusted Cox regression model using the same approach described in the primary analysis. Covariates of interest available through the EHR will be added to the model, including patient-level (e.g., race), clinician-level (e.g., physician type), and practice-level (e.g., community vs. hospital-based) data.</p>
              </sec>
            </sec>
            <sec id="Sec11">
              <title>Discussion</title>
              <p id="Par42">This study will sequentially test the effects of patient-directed strategies, sent via the patient portal and text message, and EHR-based clinician-directed strategies, sent as “pend and send” default orders, on genetic counseling engagement in gynecology practices at two distinct Penn Medicine clinics. It builds upon Penn ISC3’s prior work [<xref ref-type="bibr" rid="CR74">74</xref>, <xref ref-type="bibr" rid="CR75">75</xref>] implementing nudges to patients and clinicians by extending it to new populations who face additional barriers to engaging in evidence-based clinical practices. Sequential delivery mechanisms can reinforce the additive value of combining outreach via different communication channels, as well as facilitate comparisons between different patient outreach mechanisms. Additionally, the study demonstrates the value of RCAs and pilot testing strategies before implementing them at scale. By addressing barriers and heuristics that affect both patients and clinicians, this multi-level approach may help to define optimal strategies resulting in increased potential for success.</p>
              <p id="Par43">Substantial racial inequities exist in genetic testing, the timeliness of cancer diagnosis, and mortality rates. Implementing these strategies at diverse clinics in this study seeks to mitigate such inequities. While innovative treatments for BRCA-associated cancers (such as PARP inhibitors) are being approved, these innovations can exacerbate racial inequities in downstream outcomes and guideline-concordant receipt of these innovative treatments if genetic testing is not equitably implemented. In combination with existing racial inequities in clinicians’ recommendations for genetic testing, expanding inclusion criteria for genetic testing for all breast cancer patients may widen the divide in genetic testing uptake. Automated outreach via several communication channels aims to alleviate this inequity, and if successful, it can guide future outreach programs to extend health systems’ reach.</p>
              <p id="Par44">Nevertheless, researchers must be mindful of not overloading patients and clinicians with information and support tools. Co-designing strategies with patients and clinicians, switching from a BPA to a “pend and send” default order and the sequential nature of the study has helped mitigate this concern. While the clinics in this study serve diverse patient populations, results may not be generalizable to sites lacking a robust EHR network, capacity for genetic counseling, or leadership support. Finally, this is not a randomized trial. If the implementation strategies demonstrate a positive impact, study results can provide an initial model for encouraging genetic testing uptake and may lead to future large cluster randomized clinical trials focused on scaling these approaches at other Penn Medicine sites and beyond.</p>
            </sec>
            <sec sec-type="supplementary-material">
              <sec id="Sec12">
                <title>Supplementary Information</title>
                <p>
                  <supplementary-material content-type="local-data" id="MOESM1">
                    <media xlink:href="13012_2023_1308_MOESM1_ESM.pdf">
                      <caption>
                        <p>
                          <bold>Additional file 1.</bold>
                        </p>
                      </caption>
                    </media>
                  </supplementary-material>
                  <supplementary-material content-type="local-data" id="MOESM2">
                    <media xlink:href="13012_2023_1308_MOESM2_ESM.docx">
                      <caption>
                        <p><bold>Additional file 2.</bold> Standards for Reporting Implementation Studies: the StaRI checklist for completion.</p>
                      </caption>
                    </media>
                  </supplementary-material>
                </p>
              </sec>
            </sec>
          </body>
          <back>
            <glossary>
              <title>Abbreviations</title>
              <def-list>
                <def-item>
                  <term>BPA</term>
                  <def>
                    <p id="Par5">Best Practice Alert</p>
                  </def>
                </def-item>
                <def-item>
                  <term>BRCA</term>
                  <def>
                    <p id="Par6">Breast cancer gene</p>
                  </def>
                </def-item>
                <def-item>
                  <term>CREP</term>
                  <def>
                    <p id="Par7">Cancer Risk Evaluation Program</p>
                  </def>
                </def-item>
                <def-item>
                  <term>EHR</term>
                  <def>
                    <p id="Par8">Electronic Health Record</p>
                  </def>
                </def-item>
                <def-item>
                  <term>FDA</term>
                  <def>
                    <p id="Par9">Food and Drug Administration</p>
                  </def>
                </def-item>
                <def-item>
                  <term>HL7</term>
                  <def>
                    <p id="Par10">Health Level 7</p>
                  </def>
                </def-item>
                <def-item>
                  <term>ISC3</term>
                  <def>
                    <p id="Par11">Implementation Science Center in Cancer Control</p>
                  </def>
                </def-item>
                <def-item>
                  <term>MPM</term>
                  <def>
                    <p id="Par12">MyPennMedicine</p>
                  </def>
                </def-item>
                <def-item>
                  <term>NCCN</term>
                  <def>
                    <p id="Par13">National Comprehensive Cancer Network</p>
                  </def>
                </def-item>
                <def-item>
                  <term>NCSS</term>
                  <def>
                    <p id="Par14">Number Cruncher Statistical Systems</p>
                  </def>
                </def-item>
                <def-item>
                  <term>OB-GYN</term>
                  <def>
                    <p id="Par15">Obstetrics and Gynecology</p>
                  </def>
                </def-item>
                <def-item>
                  <term>PARP</term>
                  <def>
                    <p id="Par16">Poly (ADP-ribose) Polymerase</p>
                  </def>
                </def-item>
                <def-item>
                  <term>PASS</term>
                  <def>
                    <p id="Par17">Power Analysis &amp; Sample Size</p>
                  </def>
                </def-item>
                <def-item>
                  <term>RCA</term>
                  <def>
                    <p id="Par18">Rapid cycle approaches</p>
                  </def>
                </def-item>
                <def-item>
                  <term>TNBC</term>
                  <def>
                    <p id="Par19">Triple negative breast cancer</p>
                  </def>
                </def-item>
              </def-list>
            </glossary>
            <fn-group>
              <fn>
                <p>
                  <bold>Publisher's Note</bold>
                </p>
                <p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
              </fn>
            </fn-group>
            <ack>
              <title>Acknowledgements</title>
              <p>Not applicable.</p>
            </ack>
            <notes notes-type="author-contribution">
              <title>Authors’ contributions</title>
              <p>HS, RS, KLN, and SMD led study design. HS, RS, RSB, DB, KAR, OMF, KLN, and SMD supported paper writing. RS, RSB, and JEB obtained the study funding. HS, DB, AB, KLN, and SMD developed the study protocol and managed the study. PG, LB, and AD lead clinical informatics. HS, PG, and LB led the design of clinician nudges. JP, JC, DBM, RR, and LC serve as genetic counselor partners. RO and EGC lead the two clinics at which the trial is being implemented, and JEB and LNS support the overall implementation lab. AMB and DAA oversaw the preparation for rapid cycle approaches. KAR, RCS, and OMF led the health equity assessment. EPW is the study biostatistician. HS and MP led the design and distribution of text messages for patients. SW developed the study database.</p>
            </notes>
            <notes notes-type="funding-information">
              <title>Funding</title>
              <p>This study was supported by the National Cancer Institute grant P50 CA244690.</p>
            </notes>
            <notes notes-type="data-availability">
              <title>Availability of data and materials</title>
              <p>Not applicable.</p>
            </notes>
            <notes>
              <title>Declarations</title>
              <notes id="FPar1">
                <title>Ethics approval and consent to participate</title>
                <p id="Par45">This trial was approved by the University of Pennsylvania Institutional Review Board.</p>
              </notes>
              <notes id="FPar2">
                <title>Consent for publication</title>
                <p id="Par46">Not applicable.</p>
              </notes>
              <notes id="FPar3" notes-type="COI-statement">
                <title>Competing interests</title>
                <p id="Par47">RSB is the principal at Implementation Science &amp; Practice, LLC. She receives royalties from Oxford University Press, consulting fees from United Behavioral Health and OptumLabs, and serves on the advisory boards for Optum Behavioral Health, AIM Youth Mental Health Foundation, and the Klingenstein Third Generation Foundation outside of the submitted work. JEB reports grants from AstraZeneca, Emerson Collective, Loxo@Lilly, and Gilead and personal fees from Reimagine Care, Healthcare Foundry, and AstraZeneca, outside the submitted work. DBM reports having been a one-time consultant for Nest Genomics. DAA is a partner at VAL Health. KAR reports receiving grants from Pfizer and AstraZeneca paid to her institution, personal fees from Merck for serving as a scientific consultant, and honoraria and travel paid as an invited speaker from MJH Life Sciences outside the submitted work. KLN reports serving on a Scientific Advisory Board for Merck, unrelated to the current study. SMD reports consulting fees from AstraZeneca and GlaxoSmithKline.</p>
              </notes>
            </notes>
            <ref-list id="Bib1">
              <title>References</title>
              <ref id="CR1">
                <label>1.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Sung</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Ferlay</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Siegel</surname>
                      <given-names>RL</given-names>
                    </name>
                    <name>
                      <surname>Laversanne</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Soerjomataram</surname>
                      <given-names>I</given-names>
                    </name>
                    <name>
                      <surname>Jemal</surname>
                      <given-names>A</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries</article-title>
                  <source>CA Cancer J Clin</source>
                  <year>2021</year>
                  <volume>71</volume>
                  <issue>3</issue>
                  <fpage>209</fpage>
                  <lpage>249</lpage>
                  <pub-id pub-id-type="doi">10.3322/caac.21660</pub-id>
                  <?supplied-pmid 33538338?>
                  <pub-id pub-id-type="pmid">33538338</pub-id>
                </element-citation>
              </ref>
              <ref id="CR2">
                <label>2.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Soerjomataram</surname>
                      <given-names>I</given-names>
                    </name>
                    <name>
                      <surname>Bray</surname>
                      <given-names>F</given-names>
                    </name>
                  </person-group>
                  <article-title>Planning for tomorrow: global cancer incidence and the role of prevention 2020–2070</article-title>
                  <source>Nat Rev Clin Oncol</source>
                  <year>2021</year>
                  <volume>18</volume>
                  <issue>10</issue>
                  <fpage>663</fpage>
                  <lpage>672</lpage>
                  <pub-id pub-id-type="doi">10.1038/s41571-021-00514-z</pub-id>
                  <?supplied-pmid 34079102?>
                  <pub-id pub-id-type="pmid">34079102</pub-id>
                </element-citation>
              </ref>
              <ref id="CR3">
                <label>3.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Arnold</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Morgan</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Rumgay</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Mafra</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Singh</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Laversanne</surname>
                      <given-names>M</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Current and future burden of breast cancer: Global statistics for 2020 and 2040</article-title>
                  <source>Breast</source>
                  <year>2022</year>
                  <volume>66</volume>
                  <fpage>15</fpage>
                  <lpage>23</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.breast.2022.08.010</pub-id>
                  <?supplied-pmid 36084384?>
                  <pub-id pub-id-type="pmid">36084384</pub-id>
                </element-citation>
              </ref>
              <ref id="CR4">
                <label>4.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Siegel</surname>
                      <given-names>RL</given-names>
                    </name>
                    <name>
                      <surname>Miller</surname>
                      <given-names>KD</given-names>
                    </name>
                    <name>
                      <surname>Fuchs</surname>
                      <given-names>HE</given-names>
                    </name>
                    <name>
                      <surname>Jemal</surname>
                      <given-names>A</given-names>
                    </name>
                  </person-group>
                  <article-title>Cancer statistics, 2022</article-title>
                  <source>CA Cancer J Clin</source>
                  <year>2022</year>
                  <volume>72</volume>
                  <issue>1</issue>
                  <fpage>7</fpage>
                  <lpage>33</lpage>
                  <pub-id pub-id-type="doi">10.3322/caac.21708</pub-id>
                  <?supplied-pmid 35020204?>
                  <pub-id pub-id-type="pmid">35020204</pub-id>
                </element-citation>
              </ref>
              <ref id="CR5">
                <label>5.</label>
                <mixed-citation publication-type="other">Centers for Disease Control and Prevention. Cancer Statistics At a Glance 2019 [Available from: <ext-link ext-link-type="uri" xlink:href="https://gis.cdc.gov/Cancer/USCS/?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fcancer%2Fdataviz%2Findex.htm#/AtAGlance/">https://gis.cdc.gov/Cancer/USCS/?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fcancer%2Fdataviz%2Findex.htm#/AtAGlance/</ext-link>.</mixed-citation>
              </ref>
              <ref id="CR6">
                <label>6.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Srivastava</surname>
                      <given-names>SK</given-names>
                    </name>
                    <name>
                      <surname>Ahmad</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Miree</surname>
                      <given-names>O</given-names>
                    </name>
                    <name>
                      <surname>Patel</surname>
                      <given-names>GK</given-names>
                    </name>
                    <name>
                      <surname>Singh</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Rocconi</surname>
                      <given-names>RP</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Racial health disparities in ovarian cancer: not just black and white</article-title>
                  <source>J Ovarian Res</source>
                  <year>2017</year>
                  <volume>10</volume>
                  <issue>1</issue>
                  <fpage>58</fpage>
                  <pub-id pub-id-type="doi">10.1186/s13048-017-0355-y</pub-id>
                  <?supplied-pmid 28931403?>
                  <pub-id pub-id-type="pmid">28931403</pub-id>
                </element-citation>
              </ref>
              <ref id="CR7">
                <label>7.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Collins</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Holcomb</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Chapman-Davis</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Khabele</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Farley</surname>
                      <given-names>JH</given-names>
                    </name>
                  </person-group>
                  <article-title>Gynecologic cancer disparities: a report from the health disparities taskforce of the society of gynecologic oncology</article-title>
                  <source>Gynecol Oncol</source>
                  <year>2014</year>
                  <volume>133</volume>
                  <issue>2</issue>
                  <fpage>353</fpage>
                  <lpage>361</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.ygyno.2013.12.039</pub-id>
                  <?supplied-pmid 24406291?>
                  <pub-id pub-id-type="pmid">24406291</pub-id>
                </element-citation>
              </ref>
              <ref id="CR8">
                <label>8.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Menon</surname>
                      <given-names>U</given-names>
                    </name>
                    <name>
                      <surname>Gentry-Maharaj</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Burnell</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Singh</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Ryan</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Karpinskyj</surname>
                      <given-names>C</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial</article-title>
                  <source>Lancet</source>
                  <year>2021</year>
                  <volume>397</volume>
                  <issue>10290</issue>
                  <fpage>2182</fpage>
                  <lpage>2193</lpage>
                  <pub-id pub-id-type="doi">10.1016/S0140-6736(21)00731-5</pub-id>
                  <?supplied-pmid 33991479?>
                  <pub-id pub-id-type="pmid">33991479</pub-id>
                </element-citation>
              </ref>
              <ref id="CR9">
                <label>9.</label>
                <mixed-citation publication-type="other">Cancer Research UK. Ovarian cancer survival 2021 [Available from: <ext-link ext-link-type="uri" xlink:href="https://www.cancerresearchuk.org/about-cancer/ovarian-cancer/survival">https://www.cancerresearchuk.org/about-cancer/ovarian-cancer/survival</ext-link>.</mixed-citation>
              </ref>
              <ref id="CR10">
                <label>10.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Morris</surname>
                      <given-names>CR</given-names>
                    </name>
                    <name>
                      <surname>Sands</surname>
                      <given-names>MT</given-names>
                    </name>
                    <name>
                      <surname>Smith</surname>
                      <given-names>LH</given-names>
                    </name>
                  </person-group>
                  <article-title>Ovarian cancer: predictors of early-stage diagnosis</article-title>
                  <source>Cancer Causes Control</source>
                  <year>2010</year>
                  <volume>21</volume>
                  <issue>8</issue>
                  <fpage>1203</fpage>
                  <lpage>1211</lpage>
                  <pub-id pub-id-type="doi">10.1007/s10552-010-9547-0</pub-id>
                  <?supplied-pmid 20364367?>
                  <pub-id pub-id-type="pmid">20364367</pub-id>
                </element-citation>
              </ref>
              <ref id="CR11">
                <label>11.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Reid</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Cadiz</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Pal</surname>
                      <given-names>T</given-names>
                    </name>
                  </person-group>
                  <article-title>Disparities in genetic testing and care among Black women with hereditary breast cancer</article-title>
                  <source>Curr Breast Cancer Rep</source>
                  <year>2020</year>
                  <volume>12</volume>
                  <issue>3</issue>
                  <fpage>125</fpage>
                  <lpage>131</lpage>
                  <pub-id pub-id-type="doi">10.1007/s12609-020-00364-1</pub-id>
                  <?supplied-pmid 33603954?>
                  <pub-id pub-id-type="pmid">33603954</pub-id>
                </element-citation>
              </ref>
              <ref id="CR12">
                <label>12.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Jatoi</surname>
                      <given-names>I</given-names>
                    </name>
                    <name>
                      <surname>Sung</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Jemal</surname>
                      <given-names>A</given-names>
                    </name>
                  </person-group>
                  <article-title>The emergence of the racial disparity in U.S. breast-cancer mortality</article-title>
                  <source>N Engl J Med</source>
                  <year>2022</year>
                  <volume>386</volume>
                  <issue>25</issue>
                  <fpage>2349</fpage>
                  <lpage>52</lpage>
                  <pub-id pub-id-type="doi">10.1056/NEJMp2200244</pub-id>
                  <?supplied-pmid 35713541?>
                  <pub-id pub-id-type="pmid">35713541</pub-id>
                </element-citation>
              </ref>
              <ref id="CR13">
                <label>13.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Domchek</surname>
                      <given-names>SM</given-names>
                    </name>
                    <name>
                      <surname>Robson</surname>
                      <given-names>ME</given-names>
                    </name>
                  </person-group>
                  <article-title>Update on genetic testing in gynecologic cancer</article-title>
                  <source>J Clin Oncol</source>
                  <year>2019</year>
                  <volume>37</volume>
                  <issue>27</issue>
                  <fpage>2501</fpage>
                  <lpage>2509</lpage>
                  <pub-id pub-id-type="doi">10.1200/JCO.19.00363</pub-id>
                  <?supplied-pmid 31403865?>
                  <pub-id pub-id-type="pmid">31403865</pub-id>
                </element-citation>
              </ref>
              <ref id="CR14">
                <label>14.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Daly</surname>
                      <given-names>MB</given-names>
                    </name>
                    <name>
                      <surname>Pal</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Berry</surname>
                      <given-names>MP</given-names>
                    </name>
                    <name>
                      <surname>Buys</surname>
                      <given-names>SS</given-names>
                    </name>
                    <name>
                      <surname>Dickson</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Domchek</surname>
                      <given-names>SM</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Genetic/familial high-risk assessment: breast, ovarian, and pancreatic, version 2.2021, NCCN clinical practice guidelines in oncology</article-title>
                  <source>J Natl Compr Canc Netw</source>
                  <year>2021</year>
                  <volume>19</volume>
                  <issue>1</issue>
                  <fpage>77</fpage>
                  <lpage>102</lpage>
                  <pub-id pub-id-type="doi">10.6004/jnccn.2021.0001</pub-id>
                  <?supplied-pmid 33406487?>
                  <pub-id pub-id-type="pmid">33406487</pub-id>
                </element-citation>
              </ref>
              <ref id="CR15">
                <label>15.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Hu</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Hart</surname>
                      <given-names>SN</given-names>
                    </name>
                    <name>
                      <surname>Gnanaolivu</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Huang</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Lee</surname>
                      <given-names>KY</given-names>
                    </name>
                    <name>
                      <surname>Na</surname>
                      <given-names>J</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>A population-based study of genes previously implicated in breast cancer</article-title>
                  <source>N Engl J Med</source>
                  <year>2021</year>
                  <volume>384</volume>
                  <issue>5</issue>
                  <fpage>440</fpage>
                  <lpage>451</lpage>
                  <pub-id pub-id-type="doi">10.1056/NEJMoa2005936</pub-id>
                  <?supplied-pmid 33471974?>
                  <pub-id pub-id-type="pmid">33471974</pub-id>
                </element-citation>
              </ref>
              <ref id="CR16">
                <label>16.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Domchek</surname>
                      <given-names>SM</given-names>
                    </name>
                    <name>
                      <surname>Friebel</surname>
                      <given-names>TM</given-names>
                    </name>
                    <name>
                      <surname>Singer</surname>
                      <given-names>CF</given-names>
                    </name>
                    <name>
                      <surname>Evans</surname>
                      <given-names>DG</given-names>
                    </name>
                    <name>
                      <surname>Lynch</surname>
                      <given-names>HT</given-names>
                    </name>
                    <name>
                      <surname>Isaacs</surname>
                      <given-names>C</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality</article-title>
                  <source>JAMA</source>
                  <year>2010</year>
                  <volume>304</volume>
                  <issue>9</issue>
                  <fpage>967</fpage>
                  <lpage>975</lpage>
                  <pub-id pub-id-type="doi">10.1001/jama.2010.1237</pub-id>
                  <?supplied-pmid 20810374?>
                  <pub-id pub-id-type="pmid">20810374</pub-id>
                </element-citation>
              </ref>
              <ref id="CR17">
                <label>17.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Geyer</surname>
                      <given-names>CE</given-names>
                      <suffix>Jr</suffix>
                    </name>
                    <name>
                      <surname>Garber</surname>
                      <given-names>JE</given-names>
                    </name>
                    <name>
                      <surname>Gelber</surname>
                      <given-names>RD</given-names>
                    </name>
                    <name>
                      <surname>Yothers</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Taboada</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Ross</surname>
                      <given-names>L</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer</article-title>
                  <source>Ann Oncol</source>
                  <year>2022</year>
                  <volume>33</volume>
                  <issue>12</issue>
                  <fpage>1250</fpage>
                  <lpage>1268</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.annonc.2022.09.159</pub-id>
                  <?supplied-pmid 36228963?>
                  <pub-id pub-id-type="pmid">36228963</pub-id>
                </element-citation>
              </ref>
              <ref id="CR18">
                <label>18.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Tutt</surname>
                      <given-names>ANJ</given-names>
                    </name>
                    <name>
                      <surname>Garber</surname>
                      <given-names>JE</given-names>
                    </name>
                    <name>
                      <surname>Kaufman</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Viale</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Fumagalli</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Rastogi</surname>
                      <given-names>P</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Adjuvant Olaparib for patients with BRCA1- or BRCA2-mutated breast cancer</article-title>
                  <source>N Engl J Med</source>
                  <year>2021</year>
                  <volume>384</volume>
                  <issue>25</issue>
                  <fpage>2394</fpage>
                  <lpage>2405</lpage>
                  <pub-id pub-id-type="doi">10.1056/NEJMoa2105215</pub-id>
                  <?supplied-pmid 34081848?>
                  <pub-id pub-id-type="pmid">34081848</pub-id>
                </element-citation>
              </ref>
              <ref id="CR19">
                <label>19.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Yadav</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Jinna</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Pereira-Rodrigues</surname>
                      <given-names>O</given-names>
                    </name>
                    <name>
                      <surname>Reeves</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Campian</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Sufka</surname>
                      <given-names>A</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Impact of preoperative BRCA1/2 testing on surgical decision making in patients with newly diagnosed breast cancer</article-title>
                  <source>Breast J</source>
                  <year>2018</year>
                  <volume>24</volume>
                  <issue>4</issue>
                  <fpage>541</fpage>
                  <lpage>548</lpage>
                  <pub-id pub-id-type="doi">10.1111/tbj.13007</pub-id>
                  <?supplied-pmid 29498445?>
                  <pub-id pub-id-type="pmid">29498445</pub-id>
                </element-citation>
              </ref>
              <ref id="CR20">
                <label>20.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Hall</surname>
                      <given-names>MJ</given-names>
                    </name>
                    <name>
                      <surname>Forman</surname>
                      <given-names>AD</given-names>
                    </name>
                    <name>
                      <surname>Montgomery</surname>
                      <given-names>SV</given-names>
                    </name>
                    <name>
                      <surname>Rainey</surname>
                      <given-names>KL</given-names>
                    </name>
                    <name>
                      <surname>Daly</surname>
                      <given-names>MB</given-names>
                    </name>
                  </person-group>
                  <article-title>Understanding patient and provider perceptions and expectations of genomic medicine</article-title>
                  <source>J Surg Oncol</source>
                  <year>2015</year>
                  <volume>111</volume>
                  <issue>1</issue>
                  <fpage>9</fpage>
                  <lpage>17</lpage>
                  <pub-id pub-id-type="doi">10.1002/jso.23712</pub-id>
                  <?supplied-pmid 24992205?>
                  <pub-id pub-id-type="pmid">24992205</pub-id>
                </element-citation>
              </ref>
              <ref id="CR21">
                <label>21.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Smith-Uffen</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Bartley</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Davies</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Best</surname>
                      <given-names>M</given-names>
                    </name>
                  </person-group>
                  <article-title>Motivations and barriers to pursue cancer genomic testing: a systematic review</article-title>
                  <source>Patient Educ Couns</source>
                  <year>2021</year>
                  <volume>104</volume>
                  <issue>6</issue>
                  <fpage>1325</fpage>
                  <lpage>1334</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.pec.2020.12.024</pub-id>
                  <?supplied-pmid 33390305?>
                  <pub-id pub-id-type="pmid">33390305</pub-id>
                </element-citation>
              </ref>
              <ref id="CR22">
                <label>22.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Heck</surname>
                      <given-names>PR</given-names>
                    </name>
                    <name>
                      <surname>Meyer</surname>
                      <given-names>MN</given-names>
                    </name>
                  </person-group>
                  <article-title>Population whole exome screening: primary care provider attitudes about preparedness, information avoidance, and nudging</article-title>
                  <source>Med Clin North Am</source>
                  <year>2019</year>
                  <volume>103</volume>
                  <issue>6</issue>
                  <fpage>1077</fpage>
                  <lpage>1092</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.mcna.2019.08.004</pub-id>
                  <?supplied-pmid 31582005?>
                  <pub-id pub-id-type="pmid">31582005</pub-id>
                </element-citation>
              </ref>
              <ref id="CR23">
                <label>23.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>de Moor</surname>
                      <given-names>JS</given-names>
                    </name>
                    <name>
                      <surname>Gray</surname>
                      <given-names>SW</given-names>
                    </name>
                    <name>
                      <surname>Mitchell</surname>
                      <given-names>SA</given-names>
                    </name>
                    <name>
                      <surname>Klabunde</surname>
                      <given-names>CN</given-names>
                    </name>
                    <name>
                      <surname>Freedman</surname>
                      <given-names>AN</given-names>
                    </name>
                  </person-group>
                  <article-title>Oncologist confidence in genomic testing and implications for using multimarker tumor panel tests in practice</article-title>
                  <source>JCO Precis Oncol</source>
                  <year>2020</year>
                  <volume>4</volume>
                  <fpage>PO.19.00338</fpage>
                  <?supplied-pmid 32923869?>
                  <pub-id pub-id-type="pmid">32923869</pub-id>
                </element-citation>
              </ref>
              <ref id="CR24">
                <label>24.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>McBride</surname>
                      <given-names>CM</given-names>
                    </name>
                    <name>
                      <surname>Pathak</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Johnson</surname>
                      <given-names>CE</given-names>
                    </name>
                    <name>
                      <surname>Alberg</surname>
                      <given-names>AJ</given-names>
                    </name>
                    <name>
                      <surname>Bandera</surname>
                      <given-names>EV</given-names>
                    </name>
                    <name>
                      <surname>Barnholtz-Sloan</surname>
                      <given-names>JS</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Psychosocial factors associated with genetic testing status among African American women with ovarian cancer: results from the African American cancer epidemiology study</article-title>
                  <source>Cancer</source>
                  <year>2022</year>
                  <volume>128</volume>
                  <issue>6</issue>
                  <fpage>1252</fpage>
                  <lpage>1259</lpage>
                  <pub-id pub-id-type="doi">10.1002/cncr.34053</pub-id>
                  <?supplied-pmid 34882782?>
                  <pub-id pub-id-type="pmid">34882782</pub-id>
                </element-citation>
              </ref>
              <ref id="CR25">
                <label>25.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Lau-Min</surname>
                      <given-names>KS</given-names>
                    </name>
                    <name>
                      <surname>McCarthy</surname>
                      <given-names>AM</given-names>
                    </name>
                    <name>
                      <surname>Nathanson</surname>
                      <given-names>KL</given-names>
                    </name>
                    <name>
                      <surname>Domchek</surname>
                      <given-names>SM</given-names>
                    </name>
                  </person-group>
                  <article-title>Nationwide trends and determinants of germline BRCA1/2 testing in patients with breast and ovarian cancer</article-title>
                  <source>J Natl Compr Canc Netw</source>
                  <year>2023</year>
                  <volume>21</volume>
                  <issue>4</issue>
                  <fpage>351</fpage>
                  <lpage>8 e4</lpage>
                  <pub-id pub-id-type="doi">10.6004/jnccn.2022.7257</pub-id>
                  <?supplied-pmid 37015340?>
                  <pub-id pub-id-type="pmid">37015340</pub-id>
                </element-citation>
              </ref>
              <ref id="CR26">
                <label>26.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Lee</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Gubernick</surname>
                      <given-names>LR</given-names>
                    </name>
                    <name>
                      <surname>Brodsky</surname>
                      <given-names>AL</given-names>
                    </name>
                    <name>
                      <surname>Fehniger</surname>
                      <given-names>JE</given-names>
                    </name>
                    <name>
                      <surname>Levine</surname>
                      <given-names>DA</given-names>
                    </name>
                    <name>
                      <surname>Gerber</surname>
                      <given-names>D</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Missed opportunities: genetic counseling and testing among an ethnically diverse cohort of women with endometrial cancer</article-title>
                  <source>Gynecol Oncol</source>
                  <year>2018</year>
                  <volume>151</volume>
                  <issue>1</issue>
                  <fpage>153</fpage>
                  <lpage>158</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.ygyno.2018.07.023</pub-id>
                  <?supplied-pmid 30077346?>
                  <pub-id pub-id-type="pmid">30077346</pub-id>
                </element-citation>
              </ref>
              <ref id="CR27">
                <label>27.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kurian</surname>
                      <given-names>AW</given-names>
                    </name>
                    <name>
                      <surname>Ward</surname>
                      <given-names>KC</given-names>
                    </name>
                    <name>
                      <surname>Howlader</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Deapen</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Hamilton</surname>
                      <given-names>AS</given-names>
                    </name>
                    <name>
                      <surname>Mariotto</surname>
                      <given-names>A</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Genetic testing and results in a population-based cohort of breast cancer patients and ovarian cancer patients</article-title>
                  <source>J Clin Oncol</source>
                  <year>2019</year>
                  <volume>37</volume>
                  <issue>15</issue>
                  <fpage>1305</fpage>
                  <lpage>1315</lpage>
                  <pub-id pub-id-type="doi">10.1200/JCO.18.01854</pub-id>
                  <?supplied-pmid 30964716?>
                  <pub-id pub-id-type="pmid">30964716</pub-id>
                </element-citation>
              </ref>
              <ref id="CR28">
                <label>28.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>McCarthy</surname>
                      <given-names>AM</given-names>
                    </name>
                    <name>
                      <surname>Bristol</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Domchek</surname>
                      <given-names>SM</given-names>
                    </name>
                    <name>
                      <surname>Groeneveld</surname>
                      <given-names>PW</given-names>
                    </name>
                    <name>
                      <surname>Kim</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Motanya</surname>
                      <given-names>UN</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Health care segregation, physician recommendation, and racial disparities in BRCA1/2 testing among women with breast cancer</article-title>
                  <source>J Clin Oncol</source>
                  <year>2016</year>
                  <volume>34</volume>
                  <issue>22</issue>
                  <fpage>2610</fpage>
                  <lpage>2618</lpage>
                  <pub-id pub-id-type="doi">10.1200/JCO.2015.66.0019</pub-id>
                  <?supplied-pmid 27161971?>
                  <pub-id pub-id-type="pmid">27161971</pub-id>
                </element-citation>
              </ref>
              <ref id="CR29">
                <label>29.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Phillips</surname>
                      <given-names>KA</given-names>
                    </name>
                    <name>
                      <surname>Deverka</surname>
                      <given-names>PA</given-names>
                    </name>
                    <name>
                      <surname>Hooker</surname>
                      <given-names>GW</given-names>
                    </name>
                    <name>
                      <surname>Douglas</surname>
                      <given-names>MP</given-names>
                    </name>
                  </person-group>
                  <article-title>Genetic test availability and spending: where are we now? Where are we going?</article-title>
                  <source>Health Aff (Millwood)</source>
                  <year>2018</year>
                  <volume>37</volume>
                  <issue>5</issue>
                  <fpage>710</fpage>
                  <lpage>716</lpage>
                  <pub-id pub-id-type="doi">10.1377/hlthaff.2017.1427</pub-id>
                  <?supplied-pmid 29733704?>
                  <pub-id pub-id-type="pmid">29733704</pub-id>
                </element-citation>
              </ref>
              <ref id="CR30">
                <label>30.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Dragojlovic</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Borle</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Kopac</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Ellis</surname>
                      <given-names>U</given-names>
                    </name>
                    <name>
                      <surname>Birch</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Adam</surname>
                      <given-names>S</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Correction: the composition and capacity of the clinical genetics workforce in high-income countries: a scoping review</article-title>
                  <source>Genet Med</source>
                  <year>2020</year>
                  <volume>22</volume>
                  <issue>9</issue>
                  <fpage>1570</fpage>
                  <pub-id pub-id-type="doi">10.1038/s41436-020-0903-5</pub-id>
                  <?supplied-pmid 32651549?>
                  <pub-id pub-id-type="pmid">32651549</pub-id>
                </element-citation>
              </ref>
              <ref id="CR31">
                <label>31.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Williams</surname>
                      <given-names>MS</given-names>
                    </name>
                    <name>
                      <surname>Taylor</surname>
                      <given-names>CO</given-names>
                    </name>
                    <name>
                      <surname>Walton</surname>
                      <given-names>NA</given-names>
                    </name>
                    <name>
                      <surname>Goehringer</surname>
                      <given-names>SR</given-names>
                    </name>
                    <name>
                      <surname>Aronson</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Freimuth</surname>
                      <given-names>RR</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Genomic information for clinicians in the electronic health record: lessons learned from the clinical genome resource project and the electronic medical records and genomics network</article-title>
                  <source>Front Genet</source>
                  <year>2019</year>
                  <volume>10</volume>
                  <fpage>1059</fpage>
                  <pub-id pub-id-type="doi">10.3389/fgene.2019.01059</pub-id>
                  <?supplied-pmid 31737042?>
                  <pub-id pub-id-type="pmid">31737042</pub-id>
                </element-citation>
              </ref>
              <ref id="CR32">
                <label>32.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kho</surname>
                      <given-names>AN</given-names>
                    </name>
                    <name>
                      <surname>Rasmussen</surname>
                      <given-names>LV</given-names>
                    </name>
                    <name>
                      <surname>Connolly</surname>
                      <given-names>JJ</given-names>
                    </name>
                    <name>
                      <surname>Peissig</surname>
                      <given-names>PL</given-names>
                    </name>
                    <name>
                      <surname>Starren</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Hakonarson</surname>
                      <given-names>H</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Practical challenges in integrating genomic data into the electronic health record</article-title>
                  <source>Genet Med</source>
                  <year>2013</year>
                  <volume>15</volume>
                  <issue>10</issue>
                  <fpage>772</fpage>
                  <lpage>778</lpage>
                  <pub-id pub-id-type="doi">10.1038/gim.2013.131</pub-id>
                  <?supplied-pmid 24071798?>
                  <pub-id pub-id-type="pmid">24071798</pub-id>
                </element-citation>
              </ref>
              <ref id="CR33">
                <label>33.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Zebrowski</surname>
                      <given-names>AM</given-names>
                    </name>
                    <name>
                      <surname>Ellis</surname>
                      <given-names>DE</given-names>
                    </name>
                    <name>
                      <surname>Barg</surname>
                      <given-names>FK</given-names>
                    </name>
                    <name>
                      <surname>Sperber</surname>
                      <given-names>NR</given-names>
                    </name>
                    <name>
                      <surname>Bernhardt</surname>
                      <given-names>BA</given-names>
                    </name>
                    <name>
                      <surname>Denny</surname>
                      <given-names>JC</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Qualitative study of system-level factors related to genomic implementation</article-title>
                  <source>Genet Med</source>
                  <year>2019</year>
                  <volume>21</volume>
                  <issue>7</issue>
                  <fpage>1534</fpage>
                  <lpage>1540</lpage>
                  <pub-id pub-id-type="doi">10.1038/s41436-018-0378-9</pub-id>
                  <?supplied-pmid 30467402?>
                  <pub-id pub-id-type="pmid">30467402</pub-id>
                </element-citation>
              </ref>
              <ref id="CR34">
                <label>34.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Lau-Min</surname>
                      <given-names>KS</given-names>
                    </name>
                    <name>
                      <surname>McKenna</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Asher</surname>
                      <given-names>SB</given-names>
                    </name>
                    <name>
                      <surname>Bardakjian</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Wollack</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Bleznuck</surname>
                      <given-names>J</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Impact of integrating genomic data into the electronic health record on genetics care delivery</article-title>
                  <source>Genet Med</source>
                  <year>2022</year>
                  <volume>24</volume>
                  <fpage>2338</fpage>
                  <pub-id pub-id-type="doi">10.1016/j.gim.2022.08.009</pub-id>
                  <?supplied-pmid 36107166?>
                  <pub-id pub-id-type="pmid">36107166</pub-id>
                </element-citation>
              </ref>
              <ref id="CR35">
                <label>35.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Franck</surname>
                      <given-names>LS</given-names>
                    </name>
                    <name>
                      <surname>Kriz</surname>
                      <given-names>RM</given-names>
                    </name>
                    <name>
                      <surname>Rego</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Garman</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Hobbs</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Dimmock</surname>
                      <given-names>D</given-names>
                    </name>
                  </person-group>
                  <article-title>Implementing rapid whole-genome sequencing in critical care: a qualitative study of facilitators and barriers to new technology adoption</article-title>
                  <source>J Pediatr</source>
                  <year>2021</year>
                  <volume>237</volume>
                  <issue>237–43</issue>
                  <fpage>e2</fpage>
                </element-citation>
              </ref>
              <ref id="CR36">
                <label>36.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Owusu Obeng</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Fei</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Levy</surname>
                      <given-names>KD</given-names>
                    </name>
                    <name>
                      <surname>Elsey</surname>
                      <given-names>AR</given-names>
                    </name>
                    <name>
                      <surname>Pollin</surname>
                      <given-names>TI</given-names>
                    </name>
                    <name>
                      <surname>Ramirez</surname>
                      <given-names>AH</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Physician-reported benefits and barriers to clinical implementation of genomic medicine: a multi-site IGNITE-network survey</article-title>
                  <source>J Pers Med</source>
                  <year>2018</year>
                  <volume>8</volume>
                  <issue>3</issue>
                  <fpage>24</fpage>
                  <pub-id pub-id-type="doi">10.3390/jpm8030024</pub-id>
                  <?supplied-pmid 30042363?>
                  <pub-id pub-id-type="pmid">30042363</pub-id>
                </element-citation>
              </ref>
              <ref id="CR37">
                <label>37.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Jayasinghe</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Quinlan</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Mallett</surname>
                      <given-names>AJ</given-names>
                    </name>
                    <name>
                      <surname>Kerr</surname>
                      <given-names>PG</given-names>
                    </name>
                    <name>
                      <surname>McClaren</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Nisselle</surname>
                      <given-names>A</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Attitudes and practices of Australian nephrologists toward implementation of clinical genomics</article-title>
                  <source>Kidney Int Rep</source>
                  <year>2021</year>
                  <volume>6</volume>
                  <issue>2</issue>
                  <fpage>272</fpage>
                  <lpage>283</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.ekir.2020.10.030</pub-id>
                  <?supplied-pmid 33615052?>
                  <pub-id pub-id-type="pmid">33615052</pub-id>
                </element-citation>
              </ref>
              <ref id="CR38">
                <label>38.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Birmingham</surname>
                      <given-names>WC</given-names>
                    </name>
                    <name>
                      <surname>Agarwal</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Kohlmann</surname>
                      <given-names>W</given-names>
                    </name>
                    <name>
                      <surname>Aspinwall</surname>
                      <given-names>LG</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Bishoff</surname>
                      <given-names>J</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Patient and provider attitudes toward genomic testing for prostate cancer susceptibility: a mixed method study</article-title>
                  <source>BMC Health Serv Res</source>
                  <year>2013</year>
                  <volume>13</volume>
                  <fpage>279</fpage>
                  <pub-id pub-id-type="doi">10.1186/1472-6963-13-279</pub-id>
                  <?supplied-pmid 23870420?>
                  <pub-id pub-id-type="pmid">23870420</pub-id>
                </element-citation>
              </ref>
              <ref id="CR39">
                <label>39.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Lee</surname>
                      <given-names>YQ</given-names>
                    </name>
                    <name>
                      <surname>Yoon</surname>
                      <given-names>SY</given-names>
                    </name>
                    <name>
                      <surname>Hassan</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Padmanabhan</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Yip</surname>
                      <given-names>CH</given-names>
                    </name>
                    <name>
                      <surname>Keng</surname>
                      <given-names>WT</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Attitudes and training needs of oncologists and surgeons in mainstreaming breast cancer genetic counseling in a low-to-middle income Asian country</article-title>
                  <source>J Genet Couns</source>
                  <year>2022</year>
                  <volume>31</volume>
                  <fpage>1080</fpage>
                  <pub-id pub-id-type="doi">10.1002/jgc4.1579</pub-id>
                  <?supplied-pmid 35481858?>
                  <pub-id pub-id-type="pmid">35481858</pub-id>
                </element-citation>
              </ref>
              <ref id="CR40">
                <label>40.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Lau-Min</surname>
                      <given-names>KS</given-names>
                    </name>
                    <name>
                      <surname>Guerra</surname>
                      <given-names>CE</given-names>
                    </name>
                    <name>
                      <surname>Nathanson</surname>
                      <given-names>KL</given-names>
                    </name>
                    <name>
                      <surname>Bekelman</surname>
                      <given-names>JE</given-names>
                    </name>
                  </person-group>
                  <article-title>From race-based to precision oncology: leveraging behavioral economics and the electronic health record to advance health equity in cancer care</article-title>
                  <source>JCO Precis Oncol</source>
                  <year>2021</year>
                  <volume>5</volume>
                  <fpage>PO.20.00418</fpage>
                  <?supplied-pmid 34250405?>
                  <pub-id pub-id-type="pmid">34250405</pub-id>
                </element-citation>
              </ref>
              <ref id="CR41">
                <label>41.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kukafka</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Pan</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Silverman</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Zhang</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Chung</surname>
                      <given-names>WK</given-names>
                    </name>
                    <name>
                      <surname>Terry</surname>
                      <given-names>MB</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Patient and clinician decision support to increase genetic counseling for hereditary breast and ovarian cancer syndrome in primary care: a cluster randomized clinical trial</article-title>
                  <source>JAMA Netw Open</source>
                  <year>2022</year>
                  <volume>5</volume>
                  <issue>7</issue>
                  <fpage>e2222092</fpage>
                  <pub-id pub-id-type="doi">10.1001/jamanetworkopen.2022.22092</pub-id>
                  <?supplied-pmid 35849397?>
                  <pub-id pub-id-type="pmid">35849397</pub-id>
                </element-citation>
              </ref>
              <ref id="CR42">
                <label>42.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Tversky</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Kahneman</surname>
                      <given-names>D</given-names>
                    </name>
                  </person-group>
                  <article-title>Judgment under uncertainty: heuristics and biases</article-title>
                  <source>Science</source>
                  <year>1974</year>
                  <volume>185</volume>
                  <issue>4157</issue>
                  <fpage>1124</fpage>
                  <lpage>1131</lpage>
                  <pub-id pub-id-type="doi">10.1126/science.185.4157.1124</pub-id>
                  <?supplied-pmid 17835457?>
                  <pub-id pub-id-type="pmid">17835457</pub-id>
                </element-citation>
              </ref>
              <ref id="CR43">
                <label>43.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Roberts</surname>
                      <given-names>MC</given-names>
                    </name>
                    <name>
                      <surname>Mensah</surname>
                      <given-names>GA</given-names>
                    </name>
                    <name>
                      <surname>Khoury</surname>
                      <given-names>MJ</given-names>
                    </name>
                  </person-group>
                  <article-title>Leveraging implementation science to address health disparities in genomic medicine: examples from the field</article-title>
                  <source>Ethn Dis</source>
                  <year>2019</year>
                  <volume>29</volume>
                  <issue>Suppl 1</issue>
                  <fpage>187</fpage>
                  <lpage>192</lpage>
                  <pub-id pub-id-type="doi">10.18865/ed.29.S1.187</pub-id>
                  <?supplied-pmid 30906168?>
                  <pub-id pub-id-type="pmid">30906168</pub-id>
                </element-citation>
              </ref>
              <ref id="CR44">
                <label>44.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Gray</surname>
                      <given-names>SW</given-names>
                    </name>
                    <name>
                      <surname>Hicks-Courant</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Lathan</surname>
                      <given-names>CS</given-names>
                    </name>
                    <name>
                      <surname>Garraway</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Park</surname>
                      <given-names>ER</given-names>
                    </name>
                    <name>
                      <surname>Weeks</surname>
                      <given-names>JC</given-names>
                    </name>
                  </person-group>
                  <article-title>Attitudes of patients with cancer about personalized medicine and somatic genetic testing</article-title>
                  <source>J Oncol Pract</source>
                  <year>2012</year>
                  <volume>8</volume>
                  <issue>6</issue>
                  <fpage>329</fpage>
                  <lpage>35</lpage>
                  <pub-id pub-id-type="doi">10.1200/JOP.2012.000626</pub-id>
                  <?supplied-pmid 23598841?>
                  <pub-id pub-id-type="pmid">23598841</pub-id>
                </element-citation>
              </ref>
              <ref id="CR45">
                <label>45.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Suther</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Kiros</surname>
                      <given-names>GE</given-names>
                    </name>
                  </person-group>
                  <article-title>Barriers to the use of genetic testing: a study of racial and ethnic disparities</article-title>
                  <source>Genet Med</source>
                  <year>2009</year>
                  <volume>11</volume>
                  <issue>9</issue>
                  <fpage>655</fpage>
                  <lpage>662</lpage>
                  <pub-id pub-id-type="doi">10.1097/GIM.0b013e3181ab22aa</pub-id>
                  <?supplied-pmid 19752639?>
                  <pub-id pub-id-type="pmid">19752639</pub-id>
                </element-citation>
              </ref>
              <ref id="CR46">
                <label>46.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Steffen</surname>
                      <given-names>LE</given-names>
                    </name>
                    <name>
                      <surname>Du</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Gammon</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Mandelblatt</surname>
                      <given-names>JS</given-names>
                    </name>
                    <name>
                      <surname>Kohlmann</surname>
                      <given-names>WK</given-names>
                    </name>
                    <name>
                      <surname>Lee</surname>
                      <given-names>JH</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Genetic testing in a population-based sample of breast and ovarian cancer survivors from the REACH randomized trial: cost barriers and moderators of counseling mode</article-title>
                  <source>Cancer Epidemiol Biomarkers Prev</source>
                  <year>2017</year>
                  <volume>26</volume>
                  <issue>12</issue>
                  <fpage>1772</fpage>
                  <lpage>1780</lpage>
                  <pub-id pub-id-type="doi">10.1158/1055-9965.EPI-17-0389</pub-id>
                  <?supplied-pmid 28971986?>
                  <pub-id pub-id-type="pmid">28971986</pub-id>
                </element-citation>
              </ref>
              <ref id="CR47">
                <label>47.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Cragun</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Weidner</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Kechik</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Pal</surname>
                      <given-names>T</given-names>
                    </name>
                  </person-group>
                  <article-title>Genetic testing across young Hispanic and non-hispanic white breast cancer survivors: facilitators, barriers, and awareness of the genetic information nondiscrimination act</article-title>
                  <source>Genet Test Mol Biomarkers</source>
                  <year>2019</year>
                  <volume>23</volume>
                  <issue>2</issue>
                  <fpage>75</fpage>
                  <lpage>83</lpage>
                  <pub-id pub-id-type="doi">10.1089/gtmb.2018.0253</pub-id>
                  <?supplied-pmid 30676117?>
                  <pub-id pub-id-type="pmid">30676117</pub-id>
                </element-citation>
              </ref>
              <ref id="CR48">
                <label>48.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Glenn</surname>
                      <given-names>BA</given-names>
                    </name>
                    <name>
                      <surname>Chawla</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Bastani</surname>
                      <given-names>R</given-names>
                    </name>
                  </person-group>
                  <article-title>Barriers to genetic testing for breast cancer risk among ethnic minority women: an exploratory study</article-title>
                  <source>Ethn Dis</source>
                  <year>2012</year>
                  <volume>22</volume>
                  <issue>3</issue>
                  <fpage>267</fpage>
                  <lpage>273</lpage>
                  <?supplied-pmid 22870568?>
                  <pub-id pub-id-type="pmid">22870568</pub-id>
                </element-citation>
              </ref>
              <ref id="CR49">
                <label>49.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Hann</surname>
                      <given-names>KEJ</given-names>
                    </name>
                    <name>
                      <surname>Freeman</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Fraser</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Waller</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Sanderson</surname>
                      <given-names>SC</given-names>
                    </name>
                    <name>
                      <surname>Rahman</surname>
                      <given-names>B</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Awareness, knowledge, perceptions, and attitudes towards genetic testing for cancer risk among ethnic minority groups: a systematic review</article-title>
                  <source>BMC Public Health</source>
                  <year>2017</year>
                  <volume>17</volume>
                  <issue>1</issue>
                  <fpage>503</fpage>
                  <pub-id pub-id-type="doi">10.1186/s12889-017-4375-8</pub-id>
                  <?supplied-pmid 28545429?>
                  <pub-id pub-id-type="pmid">28545429</pub-id>
                </element-citation>
              </ref>
              <ref id="CR50">
                <label>50.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Rogith</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Yusuf</surname>
                      <given-names>RA</given-names>
                    </name>
                    <name>
                      <surname>Hovick</surname>
                      <given-names>SR</given-names>
                    </name>
                    <name>
                      <surname>Peterson</surname>
                      <given-names>SK</given-names>
                    </name>
                    <name>
                      <surname>Burton-Chase</surname>
                      <given-names>AM</given-names>
                    </name>
                    <name>
                      <surname>Li</surname>
                      <given-names>Y</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Attitudes regarding privacy of genomic information in personalized cancer therapy</article-title>
                  <source>J Am Med Inform Assoc</source>
                  <year>2014</year>
                  <volume>21</volume>
                  <issue>e2</issue>
                  <fpage>e320</fpage>
                  <lpage>e325</lpage>
                  <pub-id pub-id-type="doi">10.1136/amiajnl-2013-002579</pub-id>
                  <?supplied-pmid 24737606?>
                  <pub-id pub-id-type="pmid">24737606</pub-id>
                </element-citation>
              </ref>
              <ref id="CR51">
                <label>51.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Spranca</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Minsk</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Baron</surname>
                      <given-names>J</given-names>
                    </name>
                  </person-group>
                  <article-title>Omission and commission in judgment and choice</article-title>
                  <source>J Exp Soc Psychol</source>
                  <year>1991</year>
                  <volume>27</volume>
                  <issue>1</issue>
                  <fpage>76</fpage>
                  <lpage>105</lpage>
                  <pub-id pub-id-type="doi">10.1016/0022-1031(91)90011-T</pub-id>
                </element-citation>
              </ref>
              <ref id="CR52">
                <label>52.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Schneider</surname>
                      <given-names>JL</given-names>
                    </name>
                    <name>
                      <surname>Goddard</surname>
                      <given-names>KA</given-names>
                    </name>
                    <name>
                      <surname>Davis</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Wilfond</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Kauffman</surname>
                      <given-names>TL</given-names>
                    </name>
                    <name>
                      <surname>Reiss</surname>
                      <given-names>JA</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>"Is it worth knowing?" Focus group participants' perceived utility of genomic preconception carrier screening</article-title>
                  <source>J Genet Couns</source>
                  <year>2016</year>
                  <volume>25</volume>
                  <issue>1</issue>
                  <fpage>135</fpage>
                  <lpage>145</lpage>
                  <pub-id pub-id-type="doi">10.1007/s10897-015-9851-7</pub-id>
                  <?supplied-pmid 26093606?>
                  <pub-id pub-id-type="pmid">26093606</pub-id>
                </element-citation>
              </ref>
              <ref id="CR53">
                <label>53.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Taber</surname>
                      <given-names>JM</given-names>
                    </name>
                    <name>
                      <surname>Klein</surname>
                      <given-names>WM</given-names>
                    </name>
                    <name>
                      <surname>Ferrer</surname>
                      <given-names>RA</given-names>
                    </name>
                    <name>
                      <surname>Lewis</surname>
                      <given-names>KL</given-names>
                    </name>
                    <name>
                      <surname>Harris</surname>
                      <given-names>PR</given-names>
                    </name>
                    <name>
                      <surname>Shepperd</surname>
                      <given-names>JA</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Information avoidance tendencies, threat management resources, and interest in genetic sequencing feedback</article-title>
                  <source>Ann Behav Med</source>
                  <year>2015</year>
                  <volume>49</volume>
                  <issue>4</issue>
                  <fpage>616</fpage>
                  <lpage>621</lpage>
                  <pub-id pub-id-type="doi">10.1007/s12160-014-9679-7</pub-id>
                  <?supplied-pmid 25582989?>
                  <pub-id pub-id-type="pmid">25582989</pub-id>
                </element-citation>
              </ref>
              <ref id="CR54">
                <label>54.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Cragun</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Weidner</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Lewis</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Bonner</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Kim</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Vadaparampil</surname>
                      <given-names>ST</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Racial disparities in BRCA testing and cancer risk management across a population-based sample of young breast cancer survivors</article-title>
                  <source>Cancer</source>
                  <year>2017</year>
                  <volume>123</volume>
                  <issue>13</issue>
                  <fpage>2497</fpage>
                  <lpage>2505</lpage>
                  <pub-id pub-id-type="doi">10.1002/cncr.30621</pub-id>
                  <?supplied-pmid 28182268?>
                  <pub-id pub-id-type="pmid">28182268</pub-id>
                </element-citation>
              </ref>
              <ref id="CR55">
                <label>55.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kurian</surname>
                      <given-names>AW</given-names>
                    </name>
                    <name>
                      <surname>Griffith</surname>
                      <given-names>KA</given-names>
                    </name>
                    <name>
                      <surname>Hamilton</surname>
                      <given-names>AS</given-names>
                    </name>
                    <name>
                      <surname>Ward</surname>
                      <given-names>KC</given-names>
                    </name>
                    <name>
                      <surname>Morrow</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Katz</surname>
                      <given-names>SJ</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Genetic testing and counseling among patients with newly diagnosed breast cancer</article-title>
                  <source>JAMA</source>
                  <year>2017</year>
                  <volume>317</volume>
                  <issue>5</issue>
                  <fpage>531</fpage>
                  <lpage>534</lpage>
                  <pub-id pub-id-type="doi">10.1001/jama.2016.16918</pub-id>
                  <?supplied-pmid 28170472?>
                  <pub-id pub-id-type="pmid">28170472</pub-id>
                </element-citation>
              </ref>
              <ref id="CR56">
                <label>56.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Linfield</surname>
                      <given-names>DT</given-names>
                    </name>
                    <name>
                      <surname>Rothberg</surname>
                      <given-names>MB</given-names>
                    </name>
                    <name>
                      <surname>Pfoh</surname>
                      <given-names>ER</given-names>
                    </name>
                    <name>
                      <surname>Noss</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Cassard</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Powers</surname>
                      <given-names>JC</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Primary care physician referral practices regarding BRCA1/2 genetic counseling in a major health system</article-title>
                  <source>Breast Cancer Res Treat</source>
                  <year>2022</year>
                  <volume>195</volume>
                  <issue>2</issue>
                  <fpage>153</fpage>
                  <lpage>160</lpage>
                  <pub-id pub-id-type="doi">10.1007/s10549-022-06523-5</pub-id>
                  <?supplied-pmid 35842521?>
                  <pub-id pub-id-type="pmid">35842521</pub-id>
                </element-citation>
              </ref>
              <ref id="CR57">
                <label>57.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Stange</surname>
                      <given-names>KC</given-names>
                    </name>
                    <name>
                      <surname>Breslau</surname>
                      <given-names>ES</given-names>
                    </name>
                    <name>
                      <surname>Dietrich</surname>
                      <given-names>AJ</given-names>
                    </name>
                    <name>
                      <surname>Glasgow</surname>
                      <given-names>RE</given-names>
                    </name>
                  </person-group>
                  <article-title>State-of-the-art and future directions in multilevel interventions across the cancer control continuum</article-title>
                  <source>J Natl Cancer Inst Monogr</source>
                  <year>2012</year>
                  <volume>2012</volume>
                  <issue>44</issue>
                  <fpage>20</fpage>
                  <lpage>31</lpage>
                  <pub-id pub-id-type="doi">10.1093/jncimonographs/lgs006</pub-id>
                  <?supplied-pmid 22623592?>
                  <pub-id pub-id-type="pmid">22623592</pub-id>
                </element-citation>
              </ref>
              <ref id="CR58">
                <label>58.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Halpern</surname>
                      <given-names>SD</given-names>
                    </name>
                    <name>
                      <surname>Ubel</surname>
                      <given-names>PA</given-names>
                    </name>
                    <name>
                      <surname>Asch</surname>
                      <given-names>DA</given-names>
                    </name>
                  </person-group>
                  <article-title>Harnessing the power of default options to improve health care</article-title>
                  <source>N Engl J Med</source>
                  <year>2007</year>
                  <volume>357</volume>
                  <issue>13</issue>
                  <fpage>1340</fpage>
                  <lpage>1344</lpage>
                  <pub-id pub-id-type="doi">10.1056/NEJMsb071595</pub-id>
                  <?supplied-pmid 17898105?>
                  <pub-id pub-id-type="pmid">17898105</pub-id>
                </element-citation>
              </ref>
              <ref id="CR59">
                <label>59.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Patel</surname>
                      <given-names>MS</given-names>
                    </name>
                    <name>
                      <surname>Volpp</surname>
                      <given-names>KG</given-names>
                    </name>
                  </person-group>
                  <article-title>Leveraging insights from behavioral economics to increase the value of health-care service provision</article-title>
                  <source>J Gen Intern Med</source>
                  <year>2012</year>
                  <volume>27</volume>
                  <issue>11</issue>
                  <fpage>1544</fpage>
                  <lpage>1547</lpage>
                  <pub-id pub-id-type="doi">10.1007/s11606-012-2050-4</pub-id>
                  <?supplied-pmid 22549296?>
                  <pub-id pub-id-type="pmid">22549296</pub-id>
                </element-citation>
              </ref>
              <ref id="CR60">
                <label>60.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Patel</surname>
                      <given-names>MS</given-names>
                    </name>
                    <name>
                      <surname>Volpp</surname>
                      <given-names>KG</given-names>
                    </name>
                    <name>
                      <surname>Asch</surname>
                      <given-names>DA</given-names>
                    </name>
                  </person-group>
                  <article-title>Nudge units to improve the delivery of health care</article-title>
                  <source>N Engl J Med</source>
                  <year>2018</year>
                  <volume>378</volume>
                  <issue>3</issue>
                  <fpage>214</fpage>
                  <lpage>216</lpage>
                  <pub-id pub-id-type="doi">10.1056/NEJMp1712984</pub-id>
                  <?supplied-pmid 29342387?>
                  <pub-id pub-id-type="pmid">29342387</pub-id>
                </element-citation>
              </ref>
              <ref id="CR61">
                <label>61.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Yoong</surname>
                      <given-names>SL</given-names>
                    </name>
                    <name>
                      <surname>Hall</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Stacey</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>Grady</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Sutherland</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Wyse</surname>
                      <given-names>R</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Nudge strategies to improve healthcare providers' implementation of evidence-based guidelines, policies and practices: a systematic review of trials included within cochrane systematic reviews</article-title>
                  <source>Implement Sci</source>
                  <year>2020</year>
                  <volume>15</volume>
                  <issue>1</issue>
                  <fpage>50</fpage>
                  <pub-id pub-id-type="doi">10.1186/s13012-020-01011-0</pub-id>
                  <?supplied-pmid 32611354?>
                  <pub-id pub-id-type="pmid">32611354</pub-id>
                </element-citation>
              </ref>
              <ref id="CR62">
                <label>62.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Last</surname>
                      <given-names>BS</given-names>
                    </name>
                    <name>
                      <surname>Buttenheim</surname>
                      <given-names>AM</given-names>
                    </name>
                    <name>
                      <surname>Timon</surname>
                      <given-names>CE</given-names>
                    </name>
                    <name>
                      <surname>Mitra</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Beidas</surname>
                      <given-names>RS</given-names>
                    </name>
                  </person-group>
                  <article-title>Systematic review of clinician-directed nudges in healthcare contexts</article-title>
                  <source>BMJ Open</source>
                  <year>2021</year>
                  <volume>11</volume>
                  <issue>7</issue>
                  <fpage>e048801</fpage>
                  <pub-id pub-id-type="doi">10.1136/bmjopen-2021-048801</pub-id>
                  <?supplied-pmid 34253672?>
                  <pub-id pub-id-type="pmid">34253672</pub-id>
                </element-citation>
              </ref>
              <ref id="CR63">
                <label>63.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Beidas</surname>
                      <given-names>RS</given-names>
                    </name>
                    <name>
                      <surname>Buttenheim</surname>
                      <given-names>AM</given-names>
                    </name>
                    <name>
                      <surname>Mandell</surname>
                      <given-names>DS</given-names>
                    </name>
                  </person-group>
                  <article-title>Transforming mental health care delivery through implementation science and behavioral economics</article-title>
                  <source>JAMA Psychiat</source>
                  <year>2021</year>
                  <volume>78</volume>
                  <issue>9</issue>
                  <fpage>941</fpage>
                  <lpage>942</lpage>
                  <pub-id pub-id-type="doi">10.1001/jamapsychiatry.2021.1120</pub-id>
                </element-citation>
              </ref>
              <ref id="CR64">
                <label>64.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Takvorian</surname>
                      <given-names>SU</given-names>
                    </name>
                    <name>
                      <surname>Ladage</surname>
                      <given-names>VP</given-names>
                    </name>
                    <name>
                      <surname>Wileyto</surname>
                      <given-names>EP</given-names>
                    </name>
                    <name>
                      <surname>Mace</surname>
                      <given-names>DS</given-names>
                    </name>
                    <name>
                      <surname>Beidas</surname>
                      <given-names>RS</given-names>
                    </name>
                    <name>
                      <surname>Shulman</surname>
                      <given-names>LN</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Association of behavioral nudges with high-value evidence-based prescribing in oncology</article-title>
                  <source>JAMA Oncol</source>
                  <year>2020</year>
                  <volume>6</volume>
                  <issue>7</issue>
                  <fpage>1104</fpage>
                  <lpage>1106</lpage>
                  <pub-id pub-id-type="doi">10.1001/jamaoncol.2020.0746</pub-id>
                  <?supplied-pmid 32352478?>
                  <pub-id pub-id-type="pmid">32352478</pub-id>
                </element-citation>
              </ref>
              <ref id="CR65">
                <label>65.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Meeker</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Linder</surname>
                      <given-names>JA</given-names>
                    </name>
                    <name>
                      <surname>Fox</surname>
                      <given-names>CR</given-names>
                    </name>
                    <name>
                      <surname>Friedberg</surname>
                      <given-names>MW</given-names>
                    </name>
                    <name>
                      <surname>Persell</surname>
                      <given-names>SD</given-names>
                    </name>
                    <name>
                      <surname>Goldstein</surname>
                      <given-names>NJ</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Effect of behavioral interventions on inappropriate antibiotic prescribing among primary care practices: a randomized clinical trial</article-title>
                  <source>JAMA</source>
                  <year>2016</year>
                  <volume>315</volume>
                  <issue>6</issue>
                  <fpage>562</fpage>
                  <lpage>570</lpage>
                  <pub-id pub-id-type="doi">10.1001/jama.2016.0275</pub-id>
                  <?supplied-pmid 26864410?>
                  <pub-id pub-id-type="pmid">26864410</pub-id>
                </element-citation>
              </ref>
              <ref id="CR66">
                <label>66.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Waddell</surname>
                      <given-names>KJ</given-names>
                    </name>
                    <name>
                      <surname>Shah</surname>
                      <given-names>PD</given-names>
                    </name>
                    <name>
                      <surname>Adusumalli</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Patel</surname>
                      <given-names>MS</given-names>
                    </name>
                  </person-group>
                  <article-title>Using behavioral economics and technology to improve outcomes in cardio-oncology</article-title>
                  <source>JACC CardioOncol</source>
                  <year>2020</year>
                  <volume>2</volume>
                  <issue>1</issue>
                  <fpage>84</fpage>
                  <lpage>96</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.jaccao.2020.02.006</pub-id>
                  <?supplied-pmid 34396212?>
                  <pub-id pub-id-type="pmid">34396212</pub-id>
                </element-citation>
              </ref>
              <ref id="CR67">
                <label>67.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Rendle</surname>
                      <given-names>KA</given-names>
                    </name>
                    <name>
                      <surname>Beidas</surname>
                      <given-names>RS</given-names>
                    </name>
                  </person-group>
                  <article-title>Four strategic areas to advance equitable implementation of evidence-based practices in cancer care</article-title>
                  <source>Transl Behav Med</source>
                  <year>2021</year>
                  <volume>11</volume>
                  <issue>11</issue>
                  <fpage>1980</fpage>
                  <lpage>1988</lpage>
                  <pub-id pub-id-type="doi">10.1093/tbm/ibab105</pub-id>
                  <?supplied-pmid 34850931?>
                  <pub-id pub-id-type="pmid">34850931</pub-id>
                </element-citation>
              </ref>
              <ref id="CR68">
                <label>68.</label>
                <mixed-citation publication-type="other">Pew Research Center. Mobile Fact Sheet 2021 [updated April 7, 2021. Available from: <ext-link ext-link-type="uri" xlink:href="https://www.pewresearch.org/internet/fact-sheet/mobile/">https://www.pewresearch.org/internet/fact-sheet/mobile/</ext-link>.</mixed-citation>
              </ref>
              <ref id="CR69">
                <label>69.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Richwine</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Johnson</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Patel</surname>
                      <given-names>V</given-names>
                    </name>
                  </person-group>
                  <article-title>Disparities in patient portal access and the role of providers in encouraging access and use</article-title>
                  <source>J Am Med Inform Assoc</source>
                  <year>2023</year>
                  <volume>30</volume>
                  <issue>2</issue>
                  <fpage>308</fpage>
                  <lpage>317</lpage>
                  <pub-id pub-id-type="doi">10.1093/jamia/ocac227</pub-id>
                  <?supplied-pmid 36451262?>
                  <pub-id pub-id-type="pmid">36451262</pub-id>
                </element-citation>
              </ref>
              <ref id="CR70">
                <label>70.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Mistry</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Dunn</surname>
                      <given-names>JA</given-names>
                    </name>
                    <name>
                      <surname>Marshall</surname>
                      <given-names>A</given-names>
                    </name>
                  </person-group>
                  <article-title>A literature review of applied adaptive design methodology within the field of oncology in randomised controlled trials and a proposed extension to the CONSORT guidelines</article-title>
                  <source>BMC Med Res Methodol</source>
                  <year>2017</year>
                  <volume>17</volume>
                  <issue>1</issue>
                  <fpage>108</fpage>
                  <pub-id pub-id-type="doi">10.1186/s12874-017-0393-6</pub-id>
                  <?supplied-pmid 28720094?>
                  <pub-id pub-id-type="pmid">28720094</pub-id>
                </element-citation>
              </ref>
              <ref id="CR71">
                <label>71.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Verma</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Damrauer</surname>
                      <given-names>SM</given-names>
                    </name>
                    <name>
                      <surname>Naseer</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Weaver</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Kripke</surname>
                      <given-names>CM</given-names>
                    </name>
                    <name>
                      <surname>Guare</surname>
                      <given-names>L</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>The penn medicine biobank: towards a genomics-enabled learning healthcare system to accelerate precision medicine in a diverse population</article-title>
                  <source>J Pers Med</source>
                  <year>2022</year>
                  <volume>12</volume>
                  <issue>12</issue>
                  <fpage>1974</fpage>
                  <pub-id pub-id-type="doi">10.3390/jpm12121974</pub-id>
                  <?supplied-pmid 36556195?>
                  <pub-id pub-id-type="pmid">36556195</pub-id>
                </element-citation>
              </ref>
              <ref id="CR72">
                <label>72.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Asch</surname>
                      <given-names>DA</given-names>
                    </name>
                    <name>
                      <surname>Muller</surname>
                      <given-names>RW</given-names>
                    </name>
                    <name>
                      <surname>Volpp</surname>
                      <given-names>KG</given-names>
                    </name>
                  </person-group>
                  <article-title>Automated hovering in health care–watching over the 5000 hours</article-title>
                  <source>N Engl J Med</source>
                  <year>2012</year>
                  <volume>367</volume>
                  <issue>1</issue>
                  <fpage>1</fpage>
                  <lpage>3</lpage>
                  <pub-id pub-id-type="doi">10.1056/NEJMp1203869</pub-id>
                  <?supplied-pmid 22716935?>
                  <pub-id pub-id-type="pmid">22716935</pub-id>
                </element-citation>
              </ref>
              <ref id="CR73">
                <label>73.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Asch</surname>
                      <given-names>DA</given-names>
                    </name>
                    <name>
                      <surname>Volpp</surname>
                      <given-names>KG</given-names>
                    </name>
                  </person-group>
                  <article-title>On the way to health</article-title>
                  <source>LDI Issue Brief</source>
                  <year>2012</year>
                  <volume>17</volume>
                  <issue>9</issue>
                  <fpage>1</fpage>
                  <lpage>4</lpage>
                  <?supplied-pmid 22934330?>
                  <pub-id pub-id-type="pmid">22934330</pub-id>
                </element-citation>
              </ref>
              <ref id="CR74">
                <label>74.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Takvorian</surname>
                      <given-names>SU</given-names>
                    </name>
                    <name>
                      <surname>Bekelman</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Beidas</surname>
                      <given-names>RS</given-names>
                    </name>
                    <name>
                      <surname>Schnoll</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Clifton</surname>
                      <given-names>ABW</given-names>
                    </name>
                    <name>
                      <surname>Salam</surname>
                      <given-names>T</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Behavioral economic implementation strategies to improve serious illness communication between clinicians and high-risk patients with cancer: protocol for a cluster randomized pragmatic trial</article-title>
                  <source>Implement Sci</source>
                  <year>2021</year>
                  <volume>16</volume>
                  <issue>1</issue>
                  <fpage>90</fpage>
                  <pub-id pub-id-type="doi">10.1186/s13012-021-01156-6</pub-id>
                  <?supplied-pmid 34563227?>
                  <pub-id pub-id-type="pmid">34563227</pub-id>
                </element-citation>
              </ref>
              <ref id="CR75">
                <label>75.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Jenssen</surname>
                      <given-names>BP</given-names>
                    </name>
                    <name>
                      <surname>Schnoll</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Beidas</surname>
                      <given-names>RS</given-names>
                    </name>
                    <name>
                      <surname>Bekelman</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Bauer</surname>
                      <given-names>AM</given-names>
                    </name>
                    <name>
                      <surname>Evers-Casey</surname>
                      <given-names>S</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Cluster randomized pragmatic clinical trial testing behavioral economic implementation strategies to improve tobacco treatment for patients with cancer who smoke</article-title>
                  <source>J Clin Oncol</source>
                  <year>2023</year>
                  <volume>41</volume>
                  <fpage>4511</fpage>
                  <pub-id pub-id-type="doi">10.1200/JCO.23.00355</pub-id>
                  <?supplied-pmid 37467454?>
                  <pub-id pub-id-type="pmid">37467454</pub-id>
                </element-citation>
              </ref>
              <ref id="CR76">
                <label>76.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Asch</surname>
                      <given-names>DA</given-names>
                    </name>
                    <name>
                      <surname>Rosin</surname>
                      <given-names>R</given-names>
                    </name>
                  </person-group>
                  <article-title>Innovation as discipline, not fad</article-title>
                  <source>N Engl J Med</source>
                  <year>2015</year>
                  <volume>373</volume>
                  <issue>7</issue>
                  <fpage>592</fpage>
                  <lpage>594</lpage>
                  <pub-id pub-id-type="doi">10.1056/NEJMp1506311</pub-id>
                  <?supplied-pmid 26267619?>
                  <pub-id pub-id-type="pmid">26267619</pub-id>
                </element-citation>
              </ref>
              <ref id="CR77">
                <label>77.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Last</surname>
                      <given-names>BS</given-names>
                    </name>
                    <name>
                      <surname>Buttenheim</surname>
                      <given-names>AM</given-names>
                    </name>
                    <name>
                      <surname>Futterer</surname>
                      <given-names>AC</given-names>
                    </name>
                    <name>
                      <surname>Livesey</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Jaeger</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Stewart</surname>
                      <given-names>RE</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>A pilot study of participatory and rapid implementation approaches to increase depression screening in primary care</article-title>
                  <source>BMC Fam Pract</source>
                  <year>2021</year>
                  <volume>22</volume>
                  <issue>1</issue>
                  <fpage>228</fpage>
                  <pub-id pub-id-type="doi">10.1186/s12875-021-01550-5</pub-id>
                  <?supplied-pmid 34784899?>
                  <pub-id pub-id-type="pmid">34784899</pub-id>
                </element-citation>
              </ref>
              <ref id="CR78">
                <label>78.</label>
                <mixed-citation publication-type="other">Lee KC, Al-Ramahi N, Hahn L, Donnell T, Schonewolf L, Khan N, et al. Operationalizing equity: a rapid-cycle innovation approach to Covid-19 vaccination in black neighborhoods. NEJM Catalyst Innov Care Deliv 2021;2(2).</mixed-citation>
              </ref>
              <ref id="CR79">
                <label>79.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Green</surname>
                      <given-names>ED</given-names>
                    </name>
                    <name>
                      <surname>Gunter</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Biesecker</surname>
                      <given-names>LG</given-names>
                    </name>
                    <name>
                      <surname>Di Francesco</surname>
                      <given-names>V</given-names>
                    </name>
                    <name>
                      <surname>Easter</surname>
                      <given-names>CL</given-names>
                    </name>
                    <name>
                      <surname>Feingold</surname>
                      <given-names>EA</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Strategic vision for improving human health at The forefront of genomics</article-title>
                  <source>Nature</source>
                  <year>2020</year>
                  <volume>586</volume>
                  <issue>7831</issue>
                  <fpage>683</fpage>
                  <lpage>692</lpage>
                  <pub-id pub-id-type="doi">10.1038/s41586-020-2817-4</pub-id>
                  <?supplied-pmid 33116284?>
                  <pub-id pub-id-type="pmid">33116284</pub-id>
                </element-citation>
              </ref>
              <ref id="CR80">
                <label>80.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Stevens</surname>
                      <given-names>EM</given-names>
                    </name>
                    <name>
                      <surname>Patterson</surname>
                      <given-names>CA</given-names>
                    </name>
                    <name>
                      <surname>Tchume-Johnson</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Antiel</surname>
                      <given-names>RM</given-names>
                    </name>
                    <name>
                      <surname>Flake</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Smith-Whitley</surname>
                      <given-names>K</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Parental attitudes towards prenatal genetic testing for sickle cell disease</article-title>
                  <source>J Pediatr Hematol Oncol</source>
                  <year>2019</year>
                  <volume>41</volume>
                  <issue>8</issue>
                  <fpage>579</fpage>
                  <lpage>585</lpage>
                  <pub-id pub-id-type="doi">10.1097/MPH.0000000000001592</pub-id>
                  <?supplied-pmid 31568178?>
                  <pub-id pub-id-type="pmid">31568178</pub-id>
                </element-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
